Endocrine Abstracts

Contents

• 23rd European Congress of Endocrinology
• • The Geoffrey Harris Prize Lecture
  • • Complex problems often have simple solution - let’s move on from Hippocrates!

      ea0073ap1.1
    • Complex problems often have simple solution - let’s move on from Hippocrates!

      ea0073ap1.2
  • The European Journal of Endocrinology Prize Lecture
  • • Communication between the hypothalamus and peripheral organs in energy balance

      ea0073ap2
  • European Hormone Medal Lecture
  • • Is human reproductive health sustainable in the 21st century?

      ea0073ap3
  • Clinical Endocrinology Trust Lecture
  • • Advances on complications and therapy of cushing’s syndrome

      ea0073ap4
  • Jens Sandahl Christiansen Award
  • • Cardiovascular disease – menopause

      ea0073jsc1
• Plenary Lectures
• • Plenary 1: The hard road to new therapies against diabetes and obesity
  • • Abstract unavailable

      ea0073pl1
  • Plenary 2: Light, body clocks and sleep: Biology to new therapeutics
  • • Light, body clocks and sleep: Biology to new therapeutics

      ea0073pl2
  • Plenary 3: 1 Year in Pituitary
  • • 1 Year in Pituitary

      ea0073pl3.1
    • Abstract unavailable

      ea0073pl3.2
  • Plenary 4: Neuroendocrine stress response at single cell resolution
  • • Abstract unavailable

      ea0073pl4
  • Plenary 5: 1 Year in Bone
  • • One year in osteoporosis

      ea0073pl5.1
    • 1 year of basic research in bone

      ea0073pl5.2
  • Plenary 6: New advances in novel targets for thyroid cancer and thyroid cancer theragnostics
  • • New advances in novel targets for thyroid cancer and thyroid cancer theragnostics

      ea0073pl6
  • Plenary 7: Central and Eastern European heritage in genetics of hypopituitarism – how the prevalent ancestral PROP 1 gene variants spread overseas
  • • Central and Eastern European heritage in genetics of hypopituitarism – how the prevalent ancestral PROP1 gene variants spread overseas

      ea0073pl7
• Symposia
• • Symposium 1: The new technology in the clinical management of thyroid nodules
  • • Novel approaches beyond cytology

      ea0073s1.1
    • Can sonoelastography and artificial intelligence improve the diagnostics of thyroid nodules?

      ea0073s1.2
    • Abstract unavailable

      ea0073s1.3
  • Symposium 2: Adrenal incidentaloma
  • • Abstract unavailable

      ea0073s2.1
    • Abstract unavailable

      ea0073s2.2
    • Abstract unavailable

      ea0073s2.3
  • Symposium 3: Expanding the benefits of GLP-1R agonists
  • • Abstract unavailable

      ea0073s3.1
    • Novel biological targets for GLP-1R agonists

      ea0073s3.2
    • Abstract unavailable

      ea0073s3.3
  • Symposium 4: Peripheral neuroendocrinology
  • • Serotonergic regulation of insulin release – Hormone secretion, beta cell mass and metabolic status.

      ea0073s4.1
    • Abstract unavailable

      ea0073s4.2
    • Abstract unavailable

      ea0073s4.3
  • Symposium 5: Human foetal exposure to environmental endocrine disruptors
  • • Nutritional programming of cardio-metabolic health: The role of maternal and fetal hyperinsulinaemia

      ea0073s5.1
    • Abstract unavailable

      ea0073s5.2
    • Pubertal urinary phthalate metabolite concentrations and semen quality among young Russian men: exploring potential windows of susceptibility

      ea0073s5.3
  • Symposium 6: COVID: The sequelae of the virus
  • • Abstract unavailable

      ea0073s6.1
    • Abstract unavailable

      ea0073s6.2
    • Abstract unavailable

      ea0073s6.3
  • Symposium 7: Inheritable metabolism
  • • Abstract unavailable

      ea0073s7.1
    • Abstract unavailable

      ea0073s7.2
    • Transgenerational influences of AMH and the pathogenesis of PCOS

      ea0073s7.3
  • Symposium 8: Lessons from MDT in MEN1 patients
  • • Abstract unavailable

      ea0073s8.1
    • Abstract unavailable

      ea0073s8.2
    • Abstract unavailable

      ea0073s8.3
  • Symposium 9: Large ambitious and inspiring European prevention programs
  • • Abstract unavailable

      ea0073s9.1
    • Prevention program for male health

      ea0073s9.2
    • Abstract unavailable

      ea0073s9.3
  • Symposium 10: New approaches in pituitary pathologies from a multidisciplinary team
  • • Abstract unavailable

      ea0073s10.1
    • Tumor or not tumor and what’s new in pituitary pathology

      ea0073s10.2
    • Abstract unavailable

      ea0073s10.3
  • Symposium 11: Thyroid hormones, regulation of metabolism and energy balance
  • • Abstract unavailable

      ea0073s11.1
    • The cross talk between thyroid hormones and the central nervous system in thermoregulation

      ea0073s11.2
    • Chronic glucocorticoid treatment causes metabolic abnormalities: The role of hypothalamic glucocorticoids and DIO2

      ea0073s11.3
  • Symposium 12: What's new in cardiovascular protection and function
  • • Abstract unavailable

      ea0073s12.1
    • Abstract unavailable

      ea0073s12.2
    • Role of inflammation in the therapy of cardiometabolic diseases

      ea0073s12.3
  • Symposium 13: TGF-β signalling in ovaries in women with PCOS
  • • Interplay between androgens and TGF-β signalling in the ovary

      ea0073s13.1
    • LH-receptor activity and interaction with TGF-β family members in women with PCOS

      ea0073s13.2
    • Cell-specific expression of TGF-β family members in follicles of women with and without PCOS

      ea0073s13.3
  • Symposium 14: Complex clinical cases
  • • GH: too much, too early

      ea0073s14.1
    • Abstract unavailable

      ea0073s14.2
    • Abstract unavailable

      ea0073s14.3
  • Symposium 15: Nutrition intervention: Not just to lose weight
  • • Abstract unavailable

      ea0073s15.1
    • Abstract unavailable

      ea0073s15.2
    • Abstract unavailable

      ea0073s15.3
  • Symposium 16: Splicing in endocrine-related cancers
  • • Abstract unavailable

      ea0073s16.1
    • Alternative splicing in breast cancer

      ea0073s16.2
    • Abstract unavailable

      ea0073s16.3
  • Symposium 17: New advances in the managements of hypophosphatemia
  • • Pathogenesis and pathophysiology of hypophosphatemia

      ea0073s17.1
    • Abstract unavailable

      ea0073s17.2
    • Abstract unavailable

      ea0073s17.3
  • Symposium 18: The future of endocrinology Artificial Intelligence (AI) and big data!
  • • AI in the clinical setting

      ea0073s18.1
    • Abstract unavailable

      ea0073s18.2
    • AI in endocrine learning

      ea0073s18.3
  • Symposium 19: Emerging concerns in reproduction
  • • Influence of the pre- and post-natal environment upon metabolic physiology of the offspring

      ea0073s19.1
    • Abstract unavailable

      ea0073s19.2
    • Abstract unavailable

      ea0073s19.3
  • Symposium 20: Diabetes and bone
  • • Abstract unavailable

      ea0073s20.1
    • Abstract unavailable

      ea0073s20.2
    • Abstract unavailable

      ea0073s20.3
  • Symposium 21: Hot topics in neuroendocrine tumours
  • • Epigenetics in NENs – lessons from MEN1-NENs models

      ea0073s21.1
    • Abstract unavailable

      ea0073s21.2
    • Abstract unavailable

      ea0073s21.3
  • Symposium 22: From adrenal stem cells to ACC
  • • Adrenal cortex ageing and cancer

      ea0073s22.1
    • Abstract unavailable

      ea0073s22.2
    • Abstract unavailable

      ea0073s22.3
  • Symposium 23: Novel targets in diabesity
  • • Abstract unavailable

      ea0073s23.1
    • Abstract unavailable

      ea0073s23.2
    • Abstract unavailable

      ea0073s23.3
  • Symposium 24: Intermediate thyroid cancer soft or aggressive approach
  • • Clinical Case: Papillary thyroid cancer: A surgical disease

      ea0073s24.1
    • Abstract unavailable

      ea0073s24.2
    • Abstract unavailable

      ea0073s24.3
    • Abstract unavailable

      ea0073s24.4
  • Symposium 25: Parathyroid disorders
  • • Abstract unavailable

      ea0073s25.1
    • How to discriminate between PHPT and FHH

      ea0073s25.2
    • Abstract unavailable

      ea0073s25.3
• Joint Sessions
• • ESE/EASD Joint Session: Diabetes and growth hormone
  • • Abstract unavailable

      ea0073js1.1
    • Abstract unavailable

      ea0073js1.2
    • Abstract unavailable

      ea0073js1.3
  • ESE/ESPE Joint Session: Transition - A step into the unknown
  • • Transition of the patient with GHD

      ea0073js2.1
    • Abstract unavailable

      ea0073js2.2
    • Abstract unavailable

      ea0073js2.3
  • ESE/Endocrine Society Joint Session: Emerging endocrine abnormalities and COVID-19 outcomes
  • • Abstract unavailable

      ea0073js3.1
    • Fractures

      ea0073js3.2
    • Abstract unavailable

      ea0073js3.3
    • Abstract unavailable

      ea0073js3.4
    • Abstract unavailable

      ea0073js3.5
  • ESE/SBEM, FASEN and SMNE Joint Session: Pituitary conditions and COVID-19
  • • Acromegaly and Covid-19

      ea0073js4.1
    • Hypopituitarism & Covid-19

      ea0073js4.2
    • Abstract unavailable

      ea0073js4.3
  • ESE/KES Joint Session: COVID-19 and endocrine disorders
  • • Abstract unavailable

      ea0073js5.1
    • Abstract unavailable

      ea0073js5.2
    • Abstract unavailable

      ea0073js5.3
  • ESE/EndoERN Joint Session: Rare endocrine disorders. Improving diagnosis, management and awareness by strengthening patients and physician collaboration
  • • Abstract unavailable

      ea0073js6.1
    • Abstract unavailable

      ea0073js6.2
    • Living with androgen insensitivity syndrome - Multidisciplinary care team and research

      ea0073js6.3
    • Abstract unavailable

      ea0073js6.4
  • ESE/EASO Joint Session: Endocrine lab findings in people with obesity and their therapeutic consequences
  • • Abstract unavailable

      ea0073js7.1
    • Abstract unavailable

      ea0073js7.2
    • Abstract unavailable

      ea0073js7.3
    • Diagnostics and treatment of post - bariatric surgery hypoglycaemia

      ea0073js7.4
  • ESE/Clinical Guidelines of the European Academy of Andrology: Male specific endocrine conditions
  • • Abstract unavailable

      ea0073js8.1
    • Investigation, treatment and monitoring of functional hypogonadism in males

      ea0073js8.2
    • Investigation, treatment and monitoring of functional hypogonadism in males

      ea0073js8.3
• New Scientific Approaches
• • New Scientific Approaches 1: 3D adrenal models for the study of adrenal tumors
  • • Abstract unavailable

      ea0073nsa1
  • New Scientific Approaches 2: Regeneration or replacement of beta cells
  • • Regeneration or replacement of beta cells

      ea0073nsa2
  • New Scientific Approaches 3: Cutting-edge scientific advances
  • • Abstract unavailable

      ea0073nsa3
  • New Scientific Approaches 4: Multiplex analysis platform for endocrine disruption prediction using zebrafish
  • • Multiplex analysis platform for endocrine disruption prediction using zebrafish

      ea0073nsa4
  • New Scientific Approaches 5: Whole genome sequencing in cancer care, lessons from the 100,000 Genomes Project and opportunities for NEN
  • • Abstract unavailable

      ea0073nsa5
• Debate Sessions
• • Debate 1: Should the biochemical spectrum primary aldosteronism be expanded?
  • • Abstract unavailable

      ea0073d1.1
    • Abstract unavailable

      ea0073d1.2
  • Debate 2: CGM for all people with diabetes?
  • • Abstract unavailable

      ea0073d2.1
    • AGAINST: CGM for all people with diabetes?

      ea0073d2.2
  • Debate 3: Selenium for autoimmune thyroid disorders: necessary or unnecessary?
  • • AGAINST: Selenium for autoimmune thyroid disorders: necessary or unnecessary?

      ea0073d3.1
    • Abstract unavailable

      ea0073d3.2
  • Debate 4: Endocrine disruptors harmonisation in EU: The new EU Chemicals Strategy will speed up efficient reduction of EDC exposure for EU citizens!
  • • Abstract unavailable

      ea0073d4.1
    • Abstract unavailable

      ea0073d4.2
  • Debate 5: Treatment breaks should be mandatory in the majority of people taking oral bisphosphonates
  • • Abstract unavailable

      ea0073d5.1
    • Abstract unavailable

      ea0073d5.2
  • Debate 6: What levels of prolactin to aim for... The lower the better?
  • • Abstract unavailable

      ea0073d6.1
    • Abstract unavailable

      ea0073d6.2
• Meet The Expert Basic Scientist Sessions
• • Meet The Expert Basic Scientist 1: Histopathology of human obese adipose organ: New insights
  • • Histopathology of human obese adipose organ: New insights

      ea0073mtebs1
  • Meet The Expert Basic Scientist 2: When and how to employ molecular genetic testing in thyroid pathology?
  • • Meet The Expert Basic Scientist 2: When and how to employ molecular genetic testing in thyroid pathology?

      ea0073mtebs2
  • Meet The Expert Basic Scientist 3: Interference of EDC with thyroid hormone binding and transport impacts on neural stem cell fate: from development to ageing
  • • Abstract unavailable

      ea0073mtebs3
  • Meet The Expert Basic Scientist 4: GWAS and mendelian randomisation studies in osteoporosis diagnosis
  • • Abstract unavailable

      ea0073mtebs4
• Meet The Expert Sessions
• • Meet The Expert 1: New therapies in the treatment of thyroid ophthalmopathy
  • • New therapies in the treatment of thyroid ophthalmopathy

      ea0073mte1
  • Meet The Expert 2: Non-contraceptive therapeutic use of combined oral contraceptives in PCOS
  • • Abstract unavailable

      ea0073mte2
  • Meet The Expert 3: Long-term effects of testosterone replacement therapy
  • • Abstract unavailable

      ea0073mte3
  • Meet The Expert 4: What one should know on PRRT-lessons from clinical practice
  • • What one should know on PRRT-lessons from clinical practice

      ea0073mte4
  • Meet The Expert 5: Craniopharyngeoma management
  • • Abstract unavailable

      ea0073mte5
  • Meet The Expert 6: Difficult phaeochromocytoma cases
  • • Difficult Phaeochromocytoma cases

      ea0073mte6
  • Meet The Expert 7: Do you know how to define sarcopenic obesity?
  • • Do you know how to define sarcopenic obesity?

      ea0073mte7
  • Meet The Expert 8: GH replacement in adults
  • • Growth hormone replacement therapy in adults

      ea0073mte8
  • Meet The Expert 9: Sequential osteoporosis treatments
  • • Sequential osteoporosis treatments

      ea0073mte9
  • Meet The Expert 10: Outlook for male fertility preservation
  • • Outlook for male fertility preservation

      ea0073mte10
  • Meet The Expert 11: Cardiovascular risk reduction in endocrine patients
  • • Abstract unavailable

      ea0073mte11
  • Meet The Expert 12: Pituitary surgery bites
  • • Abstract unavailable

      ea0073mte12
  • Meet The Expert 13: Marrow adiposity and bone
  • • Abstract unavailable

      ea0073mte13
  • Meet The Expert 14: For the use of AMH as a diagnostic tool in female reproduction
  • • AMH as a diagnostic tool in female reproduction

      ea0073mte14
  • Meet The Expert 15: Challenges in genetic counseling for hereditary endocrine neoplasia syndromes
  • • Challenges in genetic counseling for hereditary endocrine neoplasia syndromes

      ea0073mte15
• Oral Communications
• • Oral Communications 1: Adrenal and Cardiovascular Endocrinology
  • • Risk of developing autonomous cortisol secretion and/or significant tumor growth in non-functioning adrenal incidentalomas during follow-up

      ea0073oc1.1
    • YAP/TAZ signaling is involved in the regulation of adrenocortical progenitors in stress

      ea0073oc1.2
    • PDE11A4 (Phosphodiesterase 11 A4) is a modulator of the primary bilateral macronodular adrenal hyperplasia (PBMAH) phenotype: genotype/phenotype analysis of a cohort of 354 patients analysed by next-generation sequencing (NGS)

      ea0073oc1.3
    • The impact of targeted treatment on echocardiographic indices in patients with overt and mild primary aldosteronism, compared to patients with essential hypertension.

      ea0073oc1.4
    • Primary results from MATCH: A randomised controlled trial in primary aldosteronism

      ea0073oc1.5
    • All-cause mortality in adrenal insufficiency patients using prednisolone or hydrocortisone replacement

      ea0073oc1.6
  • Oral Communications 2: Diabetes, Obesity, Metabolism and Nutritionw
  • • Monogenic variants in the Finnish Pediatric Diabetes Register

      ea0073oc2.1
    • Autoantibodies in prediction of diabetes after gestational diabetes – A 23-year prospective cohort study

      ea0073oc2.2
    • Long-term testosterone therapy improves glycaemic control and weight control in men with type 2 diabetes: 12-year observational data from a controlled registry study in a urological setting

      ea0073oc2.3
    • Predicting optimal diabetes drug management using AI/ ML – Developing a prototype clinical decision support algorithm.

      ea0073oc2.4
    • Genetic characterization of MODY patients in greece

      ea0073oc2.5
    • Insulin receptor isoforms in human adipogenesis: Possible role in the onset of adipose tissue expansion

      ea0073oc2.6
  • Oral Communications 3: Pituitary and Neuroendocrinology
  • • Osilodrostat is an effective and well-tolerated treatment for Cushing’s Disease (CD): Results from a Phase III, multicentre, randomized, double-blind study with an initial placebo-controlled phase (LINC 4)

      ea0073oc3.1
    • Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH–and GH-secreting pituitary neuroendocrine tumor (PitNETs) cell lines

      ea0073oc3.2
    • Metyrapone treatment in endogenous Cushing’s syndrome. Long term efficacy and safety results of the extension of the phase III/IV study PROMPT

      ea0073oc3.3
    • Truncated somatostatin receptor variant SST5TMD4 determines somatostatin analogs response in corticotropinomas

      ea0073oc3.4
    • Pregnancies after childhood craniopharyngioma – Results of KRANIOPHARYNGEOM 2000/2007

      ea0073oc3.5
    • Expression and possible role of integrins in corticotroph tumours

      ea0073oc3.6
  • Oral Communications 4: Reproductive and Developmental Endocrinology
  • • Effect of IL-1 receptor antagonism on hyperandrogenemia in women with polycystic ovary syndrome

      ea0073oc4.1
    • A molecular analysis of genes involved in disruption of hypothalamo-pituitary-gonadal axis causing delay in onset of male puberty

      ea0073oc4.2
    • Gender difference in genetic and diagnosis of congenital hypogonadotropic hypogonadism (CHH) in a large cohort from an Endo-ERN referral center

      ea0073oc4.3
    • Fertility outcomes in women with hypopituitarism compared to women with hypogonadotrophic hypogonadism in a single UK centre

      ea0073oc4.4
    • Lower level of sexual maturation rating and reduced concentrations of reproductive hormones, luteinizing hormone, follicle stimulating hormone, testosterone and estradiol in short stature children with mutations in growth hormone secretagogue receptor 1a

      ea0073oc4.5
    • The potential role of androgens as early determinants of body composition and metabolic health.

      ea0073oc4.6
  • Oral Communications 5: Thyroid
  • • Identification of iodothyronine deiodinase 2 inhibitors among FDA-approved drug library using high throughput screening

      ea0073oc5.1
    • Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS* questionnaire survey of members of the Danish Endocrine Society (*Treatment of hypothyroidism in europe by specialists: An international survey)

      ea0073oc5.2
    • Derivation of thyroid progenitors from human induced pluripotent stem cells

      ea0073oc5.3
    • The ablation of thyroid nodule’s afferent arteries before radiofrequency ablation: preliminary data.

      ea0073oc5.4
    • Role of miR-139–5p in radioiodine-refractory thyroid cancers

      ea0073oc5.5
    • Comparison of Simultaneous calcitonin washout and cytology procedure success in recurrent medullary thyroid cancer

      ea0073oc5.6
  • Oral Communications 6: Calcium and Bone
  • • Osteocalcin actives GPRC6A and calcium-sensing receptor modulating intracellular signaling pathways, cell cycle genes, and apoptosis in human parathyroid tumor cells

      ea0073oc6.1
    • AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia

      ea0073oc6.2
    • Bone material strength index is altered in patients with Cushing’s syndrome even after long-term remission

      ea0073oc6.3
    • Bisphosphonates after Denosumab withdrawal reduce the vertebral fractures incidence

      ea0073oc6.4
    • Safety, tolerability and pharmacodynamics of AZP-3601, a novel long-acting PTH analog, in healthy adults: Data from a randomized, double-blind, placebo-controlled phase 1 study

      ea0073oc6.5
    • TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism: PaTH forward open-label extension trial week 26 results

      ea0073oc6.6
  • Oral Communications 7: Diabetes, Obesity, Metabolism and Nutrition
  • • Circulating concentrations of TMAO is associated with all-cause mortality in subjects with Non-alcoholic fatty liver disease. Results from a dutch prospective cohort

      ea0073oc7.1
    • Hepatocyte GH signaling regulates carbohydrate processing in a STAT5b-independent manner

      ea0073oc7.2
    • Long-term glucocorticoids are associated with increased odds of metabolic syndrome after an intensive combined lifestyle intervention

      ea0073oc7.3
    • Liver GPR55 regulates NAFLD progression from steatosis to fibrosis

      ea0073oc7.4
    • Hepatic O-GlcNAcylated-p53 as a hub integrating the glucose counterregulatory response and insulin-suppressed gluconeogenesis

      ea0073oc7.5
    • NTCP is a new promising target for treatment of metabolic diseases: A proof of mechanism from double-blind phase I clinical trials of Hepalatide

      ea0073oc7.6
  • Oral Communications 8: Pituitary and Neuroendocrinology
  • • Expression and putative role of 14–3-3 proteins in corticotroph tumours

      ea0073oc8.1
    • Osilodrostat is an effective and well-tolerated treatment option for patients with Cushing’s disease (CD): Final results from the LINC3 study

      ea0073oc8.2
    • GFRα2 as a GPS marker: Role of GFRα2 in pituitary gland

      ea0073oc8.3
    • Novel insight into ACTH-secreting pituitary tumors biological behavior: hormone secretion and cell proliferation modulation by Ubiquitin Specific Peptidase 8 inhibitor RA-9

      ea0073oc8.4
    • The clinical effects of miR-26a, miR-16, let-7, miR-128a and miR-223 in acromegaly patients

      ea0073oc8.5
    • Increased PCSK1N in silent corticotroph pituitary adenomas may explain their “silence”

      ea0073oc8.6
  • Oral Communications 9: Endocrine-Related Cancer
  • • Thymic neuroendocrine tumor and mortality in MEN 1 patients: the spanish registry

      ea0073oc9.1
    • Utility of In1-ghrelin as a novel non-invasive diagnostic and prognostic biomarker of prostate cancer in patients with PSA in the grey-zone

      ea0073oc9.2
    • Dysregulation of alternative splicing unveils new avenues for targeting pulmonary carcinoids

      ea0073oc9.3
    • Splicing machinery landscape is dysregulated in chronic liver disease: central role of EIF4A3 in hepatocarcinogenesis.

      ea0073oc9.4
    • Reassessment of the diagnostic criteria of insulinoma: A retrospective monocentric cohort study of 72-h fasting trial in 124 patients

      ea0073oc9.5
    • Presence and pathophysiological role of sst5TMD4, an aberrant spliced variant of the somatostatin receptor subtype 5, in human high-grade astrocytomas

      ea0073oc9.6
  • Oral Communications 10: Thyroid
  • • The role of VEGF expression in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis

      ea0073oc10.1
    • NTRK fusion genes in thyroid cancer

      ea0073oc10.2
    • Predictive factors for recurrent non-diagnostic fine-needle aspiration biopsy in thyroid nodules

      ea0073oc10.3
    • Targeting TSHR and ICAM-1 for treatment of Graves’ disease in BALB/c mice

      ea0073oc10.4
    • External validation of AIBx, an artificial intelligence model for risk stratification, in surgically resected thyroid nodules

      ea0073oc10.5
    • Impact of allogeneic stem cell transplantation on thyroid function

      ea0073oc10.6
  • Oral Communications 11: Adrenal and Cardiovascular Endocrinoloyg
  • • Circulating cell-free DNA for prognostication and disease surveillance in adrenocortical carcinoma

      ea0073oc11.1
    • Extensive preclinical screening of chemotherapeutic agents and molecular targeted Inhibitors reveals potent combinatory treatment for adrenocortical carcinoma (ACC)

      ea0073oc11.2
    • Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC)

      ea0073oc11.3
    • The management of post-operative recurrences in patients with adrenocortical carcinoma (ACC): The experience of San Luigi Hospital

      ea0073oc11.4
    • Results of the ADIUVO trial, the first randomized study on post-operative adjuvant mitotane in patients with adrenocortical carcinoma

      ea0073oc11.5
    • Investigating the role of cholesterol and lipid trafficking in mitotane resistance in adrenocortical carcinoma

      ea0073oc11.6
  • Oral Communications 12: Diabetes, Obesity, Metabolism and Nutrition
  • • Prevention of glucocorticoid-induced adipose dysfunction through selective activation of β3-adrenergic signaling in mice

      ea0073oc12.1
    • Improved glucose metabolism and decreased weight gain in leptin-resistant, IGFBP2-deficient, db/db mice induced by AZP-3404, a 9-amino acid analog of IGFBP2

      ea0073oc12.2
    • Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective effect in diabetic rats with experimental myocardial infarction

      ea0073oc12.3
    • Improvements in long-term appetite-regulating hormones in response to a combined lifestyle intervention for obesity

      ea0073oc12.4
    • Effects of the ghrelin gene-derived peptides on adipose browning and thermogenesis

      ea0073oc12.5
    • Molecular and functional mapping of POMC neuronal heterogeneity in obesity

      ea0073oc12.6
  • Oral Communications 13: Pituitary and Neuroendocrinology
  • • TP53 mutations in functional corticotroph tumours: prevalence and clinical relevance

      ea0073oc13.1
    • In vitro activity of glutamate decarboxylase types, 65 and 67 in GABAergic brain-regions sleeping-process related

      ea0073oc13.2
    • Cardiovascular and metabolic safety of growth hormone treatment in adult patients with growth hormone deficiency: real-world data from two large studies in the USA and Europe

      ea0073oc13.3
    • Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-β-induced toxicity

      ea0073oc13.4
    • Potential therapeutic role of somatostatin and cortistatin in prostate cancer

      ea0073oc13.5
    • A Phase 3 Large International Noninferiority Trial (MPOWERED): Assessing Maintenance of Response to Oral Octreotide Capsules in Comparison to Injectable Somatostatin Receptor Ligands

      ea0073oc13.6
  • Oral Communications 14: Across Endocrinology
  • • Organoids as a model to study the impact of EDCs on the prostate gland.

      ea0073oc14.1
    • Optimisation of a rapid, sensitive and cost-effective rat NIS iodide uptake assay

      ea0073oc14.2
    • Is thyroid gland a target of SARS-CoV-2 infection? Results of the analysis of necropsy thyroid specimens from COVID-19 patients

      ea0073oc14.3
    • Evaluation of the hypothalamic-pituitary-adrenal axis suppression in kidney transplant recipients and its association with metabolic parameters

      ea0073oc14.4
    • The use of e-REC for capturing the occurrence of covid-19 infections in people with rare endocrine conditions

      ea0073oc14.5
    • Endocrine disorders in patients with Fabry Disease: A comprehensive reference center study

      ea0073oc14.6
  • Oral Communications 15: Late Breaking
  • • Differential steroidomic profiles of human visceral and subcutaneous adipose tissue before and after bariatric surgery-induced weight loss

      ea0073oc15.1
    • Screening for mutations in isolated central hypothyroidism reveals a novel mutation in insulin receptor substrate 4 (IRS4)

      ea0073oc15.2
    • Targeting PI3K and CDKs as effective therapeutic option for PPGLs in vitro and in vivo

      ea0073oc15.3
    • Identification of a dose range for once daily oral paltusotine in patients with acromegaly that maintains IGF-1 levels when switching from long-acting somatostatin receptor ligand therapy

      ea0073oc15.4
    • The Importance of maternal thyroid hormone for programming the cardiovascular system in the male offspring

      ea0073oc15.5
    • Genetic polymorphism (IP-10/CXCL10) and diabetes mellitus type 1

      ea0073oc15.6
  • Young Investigator Awards
  • • Circulating myomiRNAs as biomarkers of Cushing’s syndrome

      ea0073yi1
    • Efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves’ orbitopathy: Preliminary analysis of a randomized controlled trial

      ea0073yi2
    • The american lifestyle induced obesity syndrome (ALIOS) diet induces an increase in intestinal permeability and exacerbates inflammation in female and male mice via the TLR4 signalling pathway

      ea0073yi3
    • Use of C-methionine PET-CT scanning to guide management of acromegaly following primary therapy – A pragmatic prioritisation strategy to achieve maximal cost effectiveness

      ea0073yi4
    • Atlas of G protein-coupled receptors in radioiodine-refractory thyroid cancer: Novel therapeutic targets for drug repositioning?

      ea0073yi5
    • Unveiling the pathophysiological relationship between prostate cancer and obesity: miR-107 as a novel personalized diagnostic and therapeutic tool

      ea0073yi6
    • Alterations in clock genes expression in eutopic and ectopic endometrial tissue

      ea0073yi7
    • Metformin and simvastatin in combination: drugs repositioning to impair high-grade astrocytomas progression

      ea0073yi8
    • The value of liquid and solid mixed meal tests to diagnose postprandial reactive hypoglycaemic syndrome

      ea0073yi9
    • Placental expression of neurokinin B and its receptor NK3R is increased in women with polycystic ovary syndrome: results of a preliminary study

      ea0073yi10
    • Gβγ-mediated signaling regulates NIS abundance at the plasma membrane

      ea0073yi11
    • Preoperative predictors and prognostic factors of recurrence of the parathyroid carcinoma – Data of a multi-center study

      ea0073yi12
• Presented Eposters
• • Presented ePosters 1: Adrenal and Cardiovascular Endocrinology
  • • Salivary steroid and 11‑oxygenated androgen profiles in patients with congenital adrenal hyperplasia on various glucocorticoid replacement regimens

      ea0073pep1.1
    • Tildacerfont for the treatment of patients with classic congenital adrenal hyperplasia: results from a 12-week phase 2 clinical trial in adults with classic CAH

      ea0073pep1.2
    • Rationale for a reduced dexamethasone dosis in prenatal CAH therapy based on pharmacokinetic modelling

      ea0073pep1.3
    • Adrenocortical oncocytoma in a patient with classic congenital adrenal hyperplasia

      ea0073pep1.4
    • Modified-release hydrocortisone improves androgen excess and facilitates glucocorticoid dose reduction in patients with classic congenital adrenal hyperplasia: non-invasive monitoring in saliva and urine

      ea0073pep1.5
    • ARMC5 modifies cell redox state to regulate steroidogenesis and lipid metabolism in the adrenal cortex

      ea0073pep1.6
    • Adverse events of mitotane treatment in patients with adrenocortical carcinoma

      ea0073pep1.7
    • Adrenal insufficiency with chronic hyponatraemia and normal basal cortisol level: time to review the investigation of hyponatraemia

      ea0073pep1.8
  • Presented ePosters 2: Diabetes, Obesity, Metabolism and Nutrition
  • • MODY 5: a rare cause of diabetes and chronic kidney disease – a report of 10 cases

      ea0073pep2.1
    • Type 2 diabetes clusters indicate diabetes duration key in fracture risk

      ea0073pep2.2
    • The rs10830963 polymorphism of the MTNR1B gene is associated with glucose metabolism in the Czech population

      ea0073pep2.3
    • Long-term clinical benefits with early combination therapy in patients with newly diagnosed type 2 diabetes from Europe: insights from the VERIFY study

      ea0073pep2.4
    • Factors predicting insulin requirement in gestational diabetes mellitus

      ea0073pep2.5
    • The relationship between calibration accuracy and glycemic variability on CGM

      ea0073pep2.6
    • The possibility of inter-individual variability of accuracy for CGM and FGM sensors

      ea0073pep2.7
    • Association of serum uric acid concentration with diabetic retinopathy and its severity

      ea0073pep2.8
  • Presented ePosters 3: Pituitary and Neuroendocrinology
  • • Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant

      ea0073pep3.1
    • Safety results from MPOWERED, a phase 3 trial of oral octreotide capsules in adults with acromegaly

      ea0073pep3.2
    • Insulinoma-associated protein 1 (INSM1) may serve as a sensitive and specific immunohistochemical and molecular biomarker of neuroendocrine differentiation in pancreatic neuroendocrine tumors (PNETs)

      ea0073pep3.3
    • Benefits and harms of pituitary surgery for prolactinomas. A systematic review and meta-analysis

      ea0073pep3.4
    • Endocrine function after tanssphenoidal surgery in patients with non-functioning pituitary adenomas: A systematic review and meta-analysis

      ea0073pep3.5
    • Comparative study of growth hormone stimulation levels in growth hormone deficient children vs children with idiopathic short stature

      ea0073pep3.6
    • Transcriptome alteration landscape of pituitary neuroendocrine tumour tissue

      ea0073pep3.7
    • Temporary oral NaCl tablets safely increase serum sodium in hospitalised elderly patients with hyponatraemia secondary to refractory idiopathic syndrome of inappropriate diuresis (SIAD)

      ea0073pep3.8
  • Presented ePosters 4: Reproductive and Developmental Endocrinology
  • • Effect of oral contraceptives containing estradiol valerate vs. ethinyl estradiol combined with dienogest on biomarkers of coagulation – a randomized clinical trial

      ea0073pep4.1
    • Immunological and inflammatory biomarkers in non-obese patients affected by PCOS, correlation between hormonal and metabolic parameters: preliminary data

      ea0073pep4.2
    • Effects of a very low-calorie ketogenic diet on androgen levels in overweight/obese men: a single-arm uncontrolled study

      ea0073pep4.3
    • Insulin production by human spermatozoa in response to glucose stimuli

      ea0073pep4.4
    • Effects of metformin withdrawal after long and short term treatment in PCOS: observational longitudinal study

      ea0073pep4.5
    • The effect of decamethylcyclopentasiloxane exposure to maternal mice in offspring behavior

      ea0073pep4.6
    • Functional ovarian reserve in women with infertility and euthyroidism: what is the role of thyroid autoimmunity?

      ea0073pep4.7
    • Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21‑hydroxylase deficiency in Europe

      ea0073pep4.8
  • Presented ePosters 5: Thyroid
  • • A rare case of resistance to thyroid hormone with recurrent papillary thyroid carcinoma

      ea0073pep5.1
    • Low-risk papillary thyroid carcinoma: outcome predictive factors in a cohort of patients not treated with radioiodine therapy after total thyroidectomy

      ea0073pep5.2
    • Is the thyroid nodule location associated with the risk of malignancy?

      ea0073pep5.3
    • Pilot study with the luca device to optimize the diagnosis of thyroid cancer: preliminary results

      ea0073pep5.4
    • Association of microRNA expression with cervical lymph node metastases of thyroid carcinoma

      ea0073pep5.5
    • Is the igf-1ec isoform a novel biomarker for advanced differentiated thyroid cancer?

      ea0073pep5.6
    • Multifocality in papillary thyroid carcinoma. Is it always the same tumor?

      ea0073pep5.7
    • Genetic profiles of aggressive variants of papillary thyroid carcinomas

      ea0073pep5.8
  • Presented ePosters 6: Calcium and Bone
  • • Comparative evaluation of bone turnover markers in diabetic rats treated with sitagliptin, canagliflozin, empagliflozin

      ea0073pep6.1
    • Yes associated protein 1 (YAP1) expression and modulation by calcium sensing receptor activation in human parathyroid tumors

      ea0073pep6.2
    • Characterization of sarcopenia via different DXA derived indices and associations with uc-dpMGP

      ea0073pep6.3
    • A rare cause of persistent hyperparathyroidism

      ea0073pep6.4
    • The effect of intra-operative autofluorescence monitoring on unintentional parathyroid gland excision rates and post-operative PTH concentrations – a single-blind randomized controlled trial

      ea0073pep6.5
    • Cardiovascular events in adult patients with chronic hypoparathyroidism treated with rhPTH(1–84) compared with a historical control cohort

      ea0073pep6.6
    • Change in estimated glomerular filtration rate in adult patients with chronic hypoparathyroidism treated with rhPTH(1–84) compared with a historical control cohort

      ea0073pep6.7
    • Risk of chronic kidney disease in adult patients with chronic hypoparathyroidism treated with rhPTH(1–84) compared with a historical control cohort

      ea0073pep6.8
  • Presented ePosters 7: Diabetes, Obesity, Metabolism and Nutrition
  • • Effects of testosterone therapy on morphology and grade of NAFLD in obese men with functional hypogonadism and type 2 diabetes

      ea0073pep7.1
    • Resolution of severe anorexia nervosa by testosterone treatment in two male transsexual young patients

      ea0073pep7.2
    • Dapagliflozin improves transaminitis in non alcoholic fatty liver disease among adults with type 2 diabetes

      ea0073pep7.3
    • Predictors of glucagon-like peptide-1 responses following oral glucose tolerance test in 3 ethnic groups of Malaysia

      ea0073pep7.4
    • Impact of SARS-CoV-2 lockdown and seasonal variations on diabetes compensation: a retrospective study in a tertiary setting in Switzerland

      ea0073pep7.5
    • Effect of Yogic technique Shavasana in T2DM patients on BP, blood sugar fluctuations and Sleep Quality

      ea0073pep7.6
    • The impact of dipper profile on diabetes complications. A study of 197 diabetic patients

      ea0073pep7.7
    • Cholesterol-free ketogenic diet administration ameliorates experimental metabolic syndrome

      ea0073pep7.8
  • Presented ePosters 8: Pituitary and Neuroendocrinology
  • • Oral octreotide capsules lowered incidence and improved severity of acromegaly symptoms compared to injectable somatostatin receptor ligands—results from the MPOWERED trial

      ea0073pep8.1
    • Antioxidant response to DNA oxidative damage in adult growth hormone deficiency: a pilot study

      ea0073pep8.2
    • Addition of cabergoline to oral octreotide capsules may improve biochemical control in patients with acromegaly who are inadequately controlled with monotherapy

      ea0073pep8.3
    • Whole exome sequencing (WES) reveals oligogenic aetiology in a case of combined pituitary hormone deficiency (CPHD)

      ea0073pep8.4
    • Osilodrostat provides sustained control of urinary free cortisol in patients with Cushing’s disease: final results from a prospective, open-label study (LINC 2)

      ea0073pep8.5
    • Can the follow-up imaging interval for non-functioning pituitary microadenomas be extended?

      ea0073pep8.6
    • Russian hypothalamic and pituitary tumor registry (OGGO): current results

      ea0073pep8.7
    • Diagnosis and treatment of patients with neuroendocrine tumours: evidence from specialist Polish centres

      ea0073pep8.8
  • Presented ePosters 9: Endocrine-Related Cancer
  • • Long-term prognosis in patients with insulinoma

      ea0073pep9.1
    • Possible role of common RET polymorphisms in pheochromocytoma

      ea0073pep9.2
    • Pneumocystis pneumonia following surgical resection of pulmonary carcinoid causing ectopic ACTH syndrome: a case report

      ea0073pep9.3
    • Parathyroid carcinoma presenting as ventricular bigeminy in pregnancy

      ea0073pep9.4
    • Endothelial and vascular function, biomarkers and clinical presentation in patients with small intestine NETs

      ea0073pep9.5
    • Characterization of signaling pathways and molecular mechanisms underlying kisspeptin response in pancreatic neuroendocrine tumor (panNETs) cells

      ea0073pep9.6
    • Hypercalcaemia due to ovarian small cell carcinoma of the hypercalcaemic type (SCCOHT)

      ea0073pep9.7
    • Outcomes of a multicenter surveillance protocol in asymptomatic Succinate Dehydrogenase (SDH) B and C mutation carriers

      ea0073pep9.8
  • Presented ePosters 10: Thyroid
  • • A semi-automatic, non-radioactive 384-well high throughput screening DIO2 assay

      ea0073pep10.1
    • Graves’ disease and concurrent immune thrombocytopenia in a patient with albinism following alemtuzumab treatment for multiple sclerosis: a rare case report

      ea0073pep10.2
    • Levothyroxine replacement reduces BMI, HbA1c, insulin resistance, LDL-C and triglyceride in overt primary hypothyroidism in Asian Indians

      ea0073pep10.3
    • Efficacy of a combined administration of myo-inositol and vitamin D in patients with autoimmune thyroiditis

      ea0073pep10.4
    • The prevalence of intestinal metaplasia in APCA positive patients with Graves’ disease

      ea0073pep10.5
    • Influence of pro-inflammatory cytokines polymorphisms on the interrelationship between Graves’ disease and diabetes

      ea0073pep10.6
    • Novel coronavirus disease and Hashimoto’s thyroiditis in children (series of clinical cases)

      ea0073pep10.7
    • Transient hyperthyrotropinemia in outpatient children treated due to acute infections of the respiratory system

      ea0073pep10.8
  • Presented ePosters 11: Adrenal and Cardiovascular Endocrinology
  • • Fascin-1, a novel-circulating marker for the prognosis of the metastatic adrenocortical carcinoma

      ea0073pep11.1
    • Establishment of novel multidimensional models for the adrenal gland and adrenal tumors

      ea0073pep11.2
    • Identification of carbonic anhydrases III and IX in the adipose microenvironment of adrenocortical carcinoma

      ea0073pep11.3
    • Computerized tomography texture analysis in pheochromocytoma: correlation with clinical, biochemical, and histopathological data

      ea0073pep11.4
    • Pre-operative hypercortisolism and post-operative adrenal insufficiency in pheochromocytomas: a single center retrospective analysis of 168 patients

      ea0073pep11.5
    • Increased risk of cardiometabolic disease in patients with benign adrenal tumours with and without cortisol excess: a case–control study

      ea0073pep11.6
    • All-cause mortality in adrenal insufficiency patients with primary and secondary adrenal insufficiency

      ea0073pep11.7
    • Urinary steroid profiling for adrenocortical carcinoma patients’ surveillance

      ea0073pep11.8
  • Presented ePosters 12: Diabetes, Obesity, Metabolism and Nutrition
  • • Cellularity and lipolytic function of human perirenal and subcutaneous adipose tissues in patients with pheochromocytoma

      ea0073pep12.1
    • Growth factors and state of lipid peroxidation in hypertensive patients with type 2 diabetes mellitus

      ea0073pep12.2
    • Association between triglyceride-glucose index (TyG) and serum urate concentrations in young adults

      ea0073pep12.3
    • Relationship between adiponectin, TNFα and SHBG in prepubertal children with obesity

      ea0073pep12.4
    • Anthropometric and laboratory features of children with type 1 diabetes and coexisting autoimmune disorders

      ea0073pep12.5
    • Serum leptin and urine cortisol to cortisone ratio are correlated in familiar partial lipodystrophy type I (Kobberling Syndrome)

      ea0073pep12.6
    • Systems biology approach identifies key genes and related-pathways for childhood obesity

      ea0073pep12.7
    • Medicsen smartpatch: a new approach to diabetes management

      ea0073pep12.8
  • Presented ePosters 13: Pituitary and Neuroendocrinology
  • • Factors associated with Aryl hydrocarbon Interacting Protein (AIP) expression in gonadotroph pituitary neuroendocrine tumours (Pit-NETs)

      ea0073pep13.1
    • Use of free triiodothyronine level in central hypothyroidism management

      ea0073pep13.2
    • Natural history of nonfunctioning pituitary incidentalomas and adenomas. A systematic review and meta-analysis

      ea0073pep13.3
    • Long term management in aggressive thyrotropinoma

      ea0073pep13.4
    • Cushing’s syndrome and chronotype

      ea0073pep13.5
    • Improved acromegaly patient satisfaction with oral octreotide capsules compared with injectable somatostatin receptor ligands in the MPOWERED trial

      ea0073pep13.6
    • Hepcidin is lower in patients with acromegaly compared to healthy control subjects

      ea0073pep13.7
    • Use of antisense oligonucleotides as a therapy for Cushing’s disease

      ea0073pep13.8
  • Presented ePosters 14: COVID-19
  • • Is initial hypocalcemia related to poorer outcomes in COVID-19 patients?

      ea0073pep14.1
    • Selenium, zinc, and vitamin D supplementation affect the clinical course of COVID-19 infection in Hashimoto’s thyroiditis

      ea0073pep14.2
    • Multi-omics approach to analyze the molecular pato-physiology of the low T3 syndrome, observed in COVID-19 patients

      ea0073pep14.3
    • SARS‑CoV‑2: potential trigger for a cerebral venous thrombosis associated to subacute de Quervain’s thyroiditis?

      ea0073pep14.4
    • Macro-TSH as a cause of refractory hypothyroidism in a covid-19 patient: description of the first case

      ea0073pep14.5
    • Higher incidence of COVID-19 in patients with adrenal insufficiency compared with background statistics

      ea0073pep14.6
    • Psychological distress in patients with hypocortisolism during mass quarantine for Covid-19 epidemic in Italy

      ea0073pep14.7
    • Simulation via Instant Messaging – Birmingham Advance (SIMBA) model helps improve clinicians’ confidence to manage various endocrine conditions during the COVID-19 pandemic

      ea0073pep14.8
  • Presented ePosters 15: Late Breaking
  • • Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during A ketogenic diet

      ea0073pep15.1
    • Monocarboxylate transporter 8 deficiency leads to autophagy-induced persistent cathepsin-mediated thyroglobulin processing triggered by insufficient L-type amino acid transporter 2 functionality

      ea0073pep15.2
    • TGF-β increase caspase activation and migration in typical bronchial carcinoids

      ea0073pep15.3
    • Selection of the most effective genetic tests for the diabetes mellitus risk prediction in Belarus

      ea0073pep15.4
    • Pheochromocytoma secreting IL-6; an atypical presentation

      ea0073pep15.5
    • Association between diabetic retinopathy, telomere length and serum proteasome concentration in type 1 diabetes: cross-sectional study in Latvia and Lithuania

      ea0073pep15.6
    • Adherence to levothyroxine treatment and factors related with adherence in hypothyroid patients

      ea0073pep15.7
    • Aggressive follicular thyroid carcinoma in a patient with Carney complex

      ea0073pep15.8
• Audio Eposter Presentations
• • Adrenal and Cardiovascular Endocrinology
  • • Adrenocortical carcinoma treatment in the Netherlands: An analysis from the Netherlands Cancer Registry from 2014 to 2019

      ea0073aep1
    • Characteristics of pheochromocytomas/paragangliomas in Flemish population

      ea0073aep2
    • Effective metyrapon treatment of a case of neonatal cushing syndrome of unknown origin

      ea0073aep3
    • Biomarkers of cardiovascular disease and inflammation in autoimmune addison’s disease with residual adrenocortical function

      ea0073aep4
    • The role of Chchd2 protein in adrenal tumorigenesis

      ea0073aep5
    • Salivary profiles of 11-oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia

      ea0073aep6
    • Unnecessary cosyntropin stimulation tests for nonclassic congenital adrenal hyperplasia (NCAH) – shall the cut-off value of 17-hydroxyprogesterone be revised?

      ea0073aep7
    • Zona glomerulosa derived Klotho does not regulate aldosterone synthesis in young mice

      ea0073aep8
    • Effects of adrenalectomy on arterial hypertension, glucose and lipid metabolism in patients with mild autonomous cortisol secretion: preliminary results of a Randomized Clinical Trial

      ea0073aep9
    • A very rare case of extranodal lymphoma with adrenal and heart involvement

      ea0073aep10
    • The role of estimated glucose disposal rate as a predictor of insulin resistance, NAFLD and major adverse cardiovascular events in type 1 diabetes mellitus

      ea0073aep11
    • Niemann-Pick disease and endocrine disorders: A case report

      ea0073aep12
    • Epidemiology, clinical course, and genetic analysis of pheochromocytomas/paragangliomas: A single centre tertiary care experience over 16 years from crete-greece

      ea0073aep13
    • Differential phenotype of bilateral macronodular adrenal hyperplasia and other bilateral adrenal lesions with associated subclinical hypercortisolism. Study of 98 patients

      ea0073aep14
    • Effect of retinoic acid on adrenal primary cultures from patients with Cushing’s disease

      ea0073aep15
    • Typical obese patient with an adrenal incidentaloma is a menopausal female with an unilateral nonfunctioning tumor – a single centre experience

      ea0073aep16
    • Cost-effectiveness of empagliflozin plus metformin vs metformin alone as first-line therapy in patients with type 2 diabetes mellitus: An australian perspective

      ea0073aep17
    • Klinefelter syndrome: Beyond hypogonadism

      ea0073aep18
    • Aryl hydrocarbon receptor Interacting Protein (AIP) status in a functional adrenal adenoma occurring in a patient with a germline AIP mutation

      ea0073aep19
    • The association between adrenal adenomas’ size, autonomous cortisol secretion and metabolic derangements

      ea0073aep20
    • Metabolic and Inflammation markers in patients with mild autonomous cortisol secretion: preliminary results of a Randomized Clinical Trial

      ea0073aep21
    • Impact of adrenal insufficiency on female sexual function: A preliminary study

      ea0073aep22
    • Adrenal cysts – a rare entity

      ea0073aep23
    • One train may hide another: Scleromyositis in a patient with peripheral adrenal insufficiency

      ea0073aep24
    • Oral and dental manifestation of Allgrove syndrome: A case report

      ea0073aep25
    • Adrenal steroid profiling in the diagnostics of partial enzyme defects in the adrenals. Establishment of normal cut-off levels using LC-MS/MS

      ea0073aep26
    • Clinical and pathological characteristics of pheochromocytoma and paraganglioma: Single center experience

      ea0073aep27
    • Effects of sorafenib, a tyrosin kinase inhibitor, on adrenocortical cancer cell line

      ea0073aep28
    • Incidental detection of adrenal hyperplasia and mortality in patients with suspected SARS-CoV-2 Infection

      ea0073aep29
    • Repeated hormonal and radiological evaluation of hypertensive patients is necessary for correct primary aldosteronism diagnosis and treatment

      ea0073aep30
    • Unilateral extramedullary adrenal plasmocytoma: A case report

      ea0073aep31
    • A rare association of pheochromocytoma, contralateral nonfunctioning adrenal adenoma, and renal angiomyolipoma

      ea0073aep32
    • Initial therapy with empagliflozin in addition to metformin vs standard therapy alone for patients with type 2 diabetes mellitus and cardiovascular disease in qatar. A cost-effectiveness analysis

      ea0073aep33
    • Metabolic, renal and cardiovascular status in patients with primary hyperaldosteronism

      ea0073aep34
    • 24-Hour blood pressure profile in patients with adrenal insufficiency

      ea0073aep35
    • The acute effects of milk intake on calcium homeostasis and cardiovascular outcome: A randomized, crossover trial in postmenopausal women

      ea0073aep36
    • Natural history of nonfunctioning adrenal incidentalomas: A 10-year longitudinal observational study

      ea0073aep37
    • Low-renin hypertension with normal or high aldosterone levels is a cause of severe hypertension, and can be diagnosed by applying endocrine society hyperaldosteronism guidelines

      ea0073aep38
    • Increasing incidence of primary aldosteronism – yet an underdiagnosed disorder

      ea0073aep39
    • A Clinically silent, non-secretory phaeochromocytoma

      ea0073aep40
    • A case of adrenergic myocarditis in pheochromocytoma mimicking COVID-19 pneumonia

      ea0073aep41
    • A case of adrenal tuberculosis mimicking non-functioning adrenal incidentaloma

      ea0073aep42
    • Evaluation of metabolic profile and thyroid disease in non functional adrenal insidentaloma patients

      ea0073aep43
    • Bilateral adrenal masses caused by extramedullary hematopoiesis detected by 18F-FLT PET/CT

      ea0073aep44
    • The role of E47 in patients with endogenous cortisol excess

      ea0073aep45
    • High-normal serum uric acid levels in Type 2 diabetes patients with atherosclerotic cardiovascular diseases

      ea0073aep46
    • Associations between the atherogenic index of plasma, cardiovascular and metabolic risk in patients with primary hyperaldosteronism

      ea0073aep47
    • Lipid paradox in acute myocardial infarction

      ea0073aep48
    • Hair cortisol levels in patients with adrenal incidentalomas compared to healthy controls

      ea0073aep49
    • Incidentally diagnosed bilateral pheochromocytoma accompanied by urothelial carcinoma of the bladder

      ea0073aep50
    • Occult aldosteronoma mimicking degenerative spine disease

      ea0073aep51
    • Oligosymptomatic positive SDHB gene mutation paraganglioma

      ea0073aep52
    • Pheochromocytomas: Diagnosis, treatment and clinical outcomes

      ea0073aep53
    • Adrenal function recovery after successful surgery for Cushing

      ea0073aep54
    • Pulmonary metastasis of a pure oncocytic adrenocortical neoplasm after a 2 years follow up

      ea0073aep55
    • Paraganglioma in pregnancy: The need for a multidisciplinary approach

      ea0073aep56
    • The prevalence of metabolic and cardiovascular complications in patients with pheochromocytoma

      ea0073aep57
    • Diabetes and adrenal incidentaloma

      ea0073aep58
    • Computed tomography in diagnosis of non-functional adrenal adenoma

      ea0073aep59
    • Assessment of glucolipid metabolism in patients with nonfunctional adrenal incidentaloma

      ea0073aep60
    • Cushing’s syndrome induced galactorrhoea in a non - lactating female: clinical case

      ea0073aep61
    • Patients with congenital adrenal hyperplasia show an adverse cardiovascular risk profile compared to patients with autoimmune adrenalitis

      ea0073aep62
    • Prognostic factors in Adrenocortical Carcinoma: A single institution case-series

      ea0073aep63
    • The clinical, paraclinical, etiological and therapeutic profile of adrenal incidentalomas

      ea0073aep64
    • Nephrotic syndrome following resection of an adrenal incidentaloma: A case report

      ea0073aep65
    • Recurrence of a malignant corticosadrenaloma

      ea0073aep66
    • Diagnosing Cushing’s syndrome due to Ectopic ACTH secretion warrants high Index of Suspicion- phenotypical features may not always present

      ea0073aep67
    • Primary hyperaldosteronism. A clinical profile of the disease without arterial hypertension

      ea0073aep68
    • Quality of life in children diagnosed with non-classic congenital adrenal hyperplasia

      ea0073aep69
    • Metabolic profile and cardiovascular risk assessment in subclinical cushing’s syndrome

      ea0073aep70
    • The insulin tolerance test (ITT) in the assessment of the adrenal axis

      ea0073aep71
    • Metabolic impact of glucocorticoid substitution in Addison’s disease

      ea0073aep72
    • Late night salivary cortisol and Cushing’s syndrome

      ea0073aep73
    • Spontaneous testicular necrosis revealing a pheochromocytoma

      ea0073aep74
    • Bilateral pheochromocytoma in von hippel-lindau syndrome revealed by a hemangioblastoma

      ea0073aep75
    • Quality of life in patients with classical form of congenital adrenal hyperplasia- deficiency of 21 hydroxylase

      ea0073aep76
    • Hyperthermia differentially affects cortisol and aldosterone secretion under stimulated conditions

      ea0073aep77
    • Bilateral adrenal leiomyoma mimicking adrenal malignancy: A rare case report

      ea0073aep78
    • Hypokalemia in a patient with severe SARS-CoV-2 infection

      ea0073aep79
    • A giant nonfunctioning adrenocortical carcinoma: A case report

      ea0073aep80
  • Calcium and Bone
  • • Bone consequences of high dose denosumab to treat an aneurysmal bone cyst, an example of the European Reference Network support

      ea0073aep81
    • Correlation between parathyroid adenoma volume and markers of calcium-phosphate metabolism in patients with primary hyperparathyroidism

      ea0073aep82
    • Efficacy and safety of long-term treatment with monthly calcifediol soft capsules in vitamin D deficient patients

      ea0073aep83
    • Non-nuclear cataracts in hypoparathyroidism are associated with biochemical control of the disease

      ea0073aep84
    • Total and free vitamin D metabolites in female primary hyperparathyroidism patients

      ea0073aep85
    • A rare case of hypercalcemia in pregnancy- a diagnostic conundrum

      ea0073aep86
    • Effect of parathyroidectomy on early diastolic dysfunction assessed with ventricular mass index in patients with primary hyperparathyroidism

      ea0073aep87
    • Bone mineral density evolution following long-term simultaneous pancreas-kidney transplantation in type 1 diabetes

      ea0073aep88
    • Normalization of SIAD-induced hyponatremia stimulates osteoblast function

      ea0073aep89
    • Fibrosis 4 score is associated with bone density measures in postmenopausal women

      ea0073aep90
    • Primary hyperparathyroidism: Differences in presentation between older and younger patients

      ea0073aep91
    • Primary hyperparathyroidism – a contemporary picture based on 100 patients from the last decade

      ea0073aep92
    • Quantifying the real-world clinical and economic burden of chronic hypoparathyroidism on secondary care in England: A multi-arm, retrospective cohort study

      ea0073aep93
    • ’Primary hyperparathyroidism: Relationship between localisation of adenoma and calcium level’

      ea0073aep94
    • High dose short term glucocorticoid (gc) treatment seems to have no long term negative effect on bone mineral density (bmd) of newly diagnosed multiple sclerosis (ms) patients

      ea0073aep95
    • Normocalcemic primary hyperparathyroidism – an early stage of hypercalcemic hyperparathyroidism?

      ea0073aep96
    • Osteoporosis and prevalent vertebral fractures are associated with insulin resistance in non-diabetic postmenopausal women

      ea0073aep97
    • The bone impact of body composition, adipokines and FGF23-Klotho axis in active acromegaly

      ea0073aep98
    • Recurrent primary hyperparathyroidism due to ectopic retropharygeal adenoma

      ea0073aep99
    • Denosumab rebound effect associated with breast cancer recurrence – a coincidence? Case report

      ea0073aep100
    • Association of preoperative factors and postoperative hypocalcemia after parathyroidectomy for primary hyperparathyroidism

      ea0073aep101
    • Which patients with primary hyperparathyroidism were not referred for surgery? A single-center experience

      ea0073aep102
    • F18-choline PET/CT for primary hyperparathyroidism localization

      ea0073aep103
    • Evaluation of bone quality by dxa-based bone strain index in primary hyperparathyroidism

      ea0073aep104
    • Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab

      ea0073aep105
    • Mineral and bone disorders in patients after combined kidney-pancreas or kidney transplantation

      ea0073aep106
    • New variant of the casr gene (c.2459c > t) associated with primary hypoparathyrodism – a case report

      ea0073aep107
    • PET/CT with 11C-methionine in the diagnosis of primary hyperparathyroidism

      ea0073aep108
    • Frequency of metabolic syndrome in Paget’s disease of bone

      ea0073aep109
    • Is necessary long-term follow-up of all patients with primary sporadic hyperparathyroidism undergoing parathyroidectomy?

      ea0073aep110
    • The challenge of genetic workup in hypercalcaemia suspected hyperparathyroidism

      ea0073aep111
    • 4D-CT – is it useful in Hyperparathyroidism?

      ea0073aep112
    • The effect of food supplement with calcium and vitamin D3 administration on calcium homeostasis and falls incidence in patients with high fracture risk undergoing medical rehabilitation

      ea0073aep113
    • Vitamin D deficiency is a key element in COVID-19 hypocalcemia

      ea0073aep114
    • Transient hypocalcaemia and definitive hypoparathyroidism after total thyroidectomy in Graves’ disease

      ea0073aep115
    • European Registries for Rare Endocrine Conditions (EuRRECa): The use of an e-reporting tool for registering calcium and phosphate conditions

      ea0073aep116
    • Skeletal and bone defects in Turner syndrome

      ea0073aep117
    • A retrospective review of the management of skeletal effects following thyroid stimulating hormone suppression therapy (tshst) in patients treated for differentiated thyroid carcinoma (dtc)

      ea0073aep118
    • Interest of the ’single photon emission tomography computed tomography’ in an atypical location of a parathyroid adenoma

      ea0073aep119
    • An unusual case of primary hyperparathyroidism due to hyperplasia resembling tertiary hyperparathyroidism

      ea0073aep120
    • The endocrine effects of lithium treatment. Report of a case

      ea0073aep121
    • Ectopic parathyroid adenomas: where to find them?

      ea0073aep122
    • Prevalence, characteristics, and associated factors of Fahr’s syndrome in permanent hypoparathyroidism

      ea0073aep123
    • The natural history of hypoparathyroidism according to the database of endocrinology research centre

      ea0073aep124
    • Summer sunshine exposure and vitamin d status in young and middle age poles: is 30 ng/ml Vitamin D cut-off really suitable for the polish population?

      ea0073aep125
    • How frequent is vitamin D toxicity? Data from the national survey of endocrinologists in Russia

      ea0073aep126
    • Large parathyroid adenomas: unusual clinical characteristics

      ea0073aep127
    • COVID-19 and impaired calcium metabolism upon admission to the hospital

      ea0073aep128
    • CDC73 associated primary hyperparathyroidism and essential tremor

      ea0073aep129
    • The benign course of MEN I disease. Implications for treatment

      ea0073aep130
    • Hypercalciuria and associated mineral metabolism disorders in osteopenic/osteoporotic patients: effects of treatment with thiazide diuretics

      ea0073aep131
    • Bone mineral density evolution after Denosumab withdrawal

      ea0073aep132
    • Serum and urinary calcium level in Latvian patients with sarcoidosis at the time of diagnosis – 2013–2018 data

      ea0073aep133
    • FGF23 secreting mesenchymal tumor of the foot: Localizing pitfalls

      ea0073aep134
    • Osteoporosis treatment following osteoporotic fractures- data from a single medical center

      ea0073aep135
    • Relationship between muscle function and trabecular bone score (TBS) in Type 2 diabetes mellitus

      ea0073aep136
    • Predictive factors for postoperative hypoparathyroidism after total thyroidectomy

      ea0073aep137
    • Continuous rhPTH(1–34) Treatment in Chronic Hypoparathyroidism

      ea0073aep138
    • Metabolic disorders in patients with primary hyperparathyroidism

      ea0073aep139
    • Parathyroid crisis – a conspicuous case of hypercalcemia

      ea0073aep140
    • Aggressive hypercalcaemia with recurrent giant parathyroid adenoma following three parathyroidectomies

      ea0073aep141
    • Height loss is almost 3 times more correlated with trabecular bone score than with bone mineral density

      ea0073aep142
    • Postsurgical hungry bone syndrome in unrecognized severe primary hyperparathyroidism: A case report

      ea0073aep143
    • Quality of life changes in patients with primary hyperparathyroidism after parathyroidectomy: The usefulness of PHPQoL questionnaire in clinical practice

      ea0073aep144
    • Adjuvant endocrine therapy impact on bone health in premenopausal women with hormone receptor-positive breast cancer: Results of a case series

      ea0073aep145
    • Parathyroid elastography―elastography evaluation algorithm

      ea0073aep146
    • Topographic diagnosis of primary hyperparathyroidism

      ea0073aep147
    • Paraplegia: a serious consequence of treatment delay in hyperparathyroidism During the COVID-19 pandemic

      ea0073aep148
    • Brown tumours resulting of secondary hyperparathyroidism in patients with chronic renal insufficiency

      ea0073aep149
    • Symptomatic mastoidian brown tumor in a dialysed child

      ea0073aep150
    • Phosphaturic mesenchymal tumour – diagnostic and therapeutic challenges

      ea0073aep151
    • The relevance of the problem of osteoporosis for medical professionals working in the field of physical and rehabilitation medicine

      ea0073aep152
    • Unexpected association of severe hypercalcemia and hypophosphatemia in a patient with chronic hypoparathyroidism: A case report

      ea0073aep153
    • Male osteoporosis

      ea0073aep154
    • 8 cases of parathyroid cancer: One-center experience

      ea0073aep155
  • Diabetes, Obesity, Metabolism and Nutrition
  • • The association of vitamin D with peripheral neuropathy among prediabetic individuals and the effect of vitamin D supplementation

      ea0073aep156
    • Lipid accumulation product can accurately rule out, but not rule in non-alcoholic fatty liver disease in type 1 diabetes

      ea0073aep157
    • Assessment of serum adiponectin levels in patients with type 1 diabetes and chronic kidney disease

      ea0073aep158
    • Pharmacogenetics of metformin in polycystic ovary syndrome and type 2 diabetes mellitus

      ea0073aep159
    • Could we use SGLT2 inhibitors without serious concern in the elderly?

      ea0073aep160
    • An analysis of flash glucose monitoring (FGM) data on insulin-treated patients with diabetes: Effects of COVID-19 lockdown

      ea0073aep161
    • Effects of long-term testosterone therapy on anthropometric parameters in men with functional hypogonadism and obesity: 12-year observational data from a controlled registry study in a urological setting

      ea0073aep162
    • Semaglutide reduces fat accumulation in the tongue of obese women with polycystic ovary syndrome: A randomized, placebo-controlled prospective study

      ea0073aep163
    • The short-term effect of surgical and pharmacological intervention in obesity caused by MC4R deficiency: A single centre experience

      ea0073aep164
    • Circulating microRNAs as predictive tool of the effectiveness of lifestyle intervention for weight loss

      ea0073aep165
    • The ecology of the microbiome in children with obesity is associated to insulin resistance anddiet composition

      ea0073aep166
    • Amniotic membrane treatment of an oxidative stress murine chronic diabetic wound model

      ea0073aep167
    • Use of the thrombolysis in myocardial infarction risk score for heart failure in diabetes in a type 2 diabetes mellitus outpatient population

      ea0073aep168
    • Glycemic control and complication rate through pregnancy and thirteen-years post-partum in women with microalbuminuria (type 1 diabetes T1DM)

      ea0073aep169
    • Impact of social isolation and quarantine on the course of diabetes mellitus and its complications during Covid 19 pandemic in Adjara Region Country of Georgia

      ea0073aep170
    • Risk factors of cardiovascular autonomic neuropathy in patients with prediabetes and coronary artery disease

      ea0073aep171
    • NaKATPase activity regulated by glycemia level in patients with DM

      ea0073aep172
    • Hirata’s disease (Insulin autoimmune syndrome) in an Egyptian female patient: A case report

      ea0073aep173
    • Severe postprandial hypoglycemia as a possible sequel of COVID-19

      ea0073aep174
    • Increased anxiety, depression and body dysmorphia in women with polycystic ovary syndrome: Results from blue morpho survey

      ea0073aep175
    • COVID-19 and diabetes: Impact on emergency department demand by diabetic patients. experience from a portuguese center

      ea0073aep176
    • ER stress and toxic soluble misfolded proteins are present in diabetes and diabetic ketoacidosis in a sex dependent-manner

      ea0073aep177
    • High prevalence of 1^st trimester gestational diabetes mellitus in polish women is accompanied by insulin resistance similar to pcos cohort

      ea0073aep178
    • Mother’s education with type 1 diabetes and the risk of some neonatal outcomes

      ea0073aep179
    • Vitamin B12 status and maternal-fetal outcomes among women with gestational diabetes

      ea0073aep180
    • Glucagon levels in women with Alzheimer’s disease

      ea0073aep181
    • Glycemic control in patients with different types of diabetes mellitus in Ukraine

      ea0073aep182
    • Increase in PUFA and in protein intake leads to reduction of liver fat independently of weight loss in 12 months: the NutriAct trial

      ea0073aep183
    • Diabetes mellitus is associated with a higher relative risk for Parkinson’s disease in women than in men

      ea0073aep184
    • Anemia in diabetes and pre-diabetes with normal kidney function: Prevalence and long- term association with morbidity and mortality

      ea0073aep185
    • Cardiorenal outcomes and T2DM control in new users of SGLT2 inhibitors in combination therapy

      ea0073aep186
    • Free T4 is associated with exenatide-related weight loss in patients with type 2 diabetes mellitus

      ea0073aep187
    • Feasibility study of IoT telemonitoring for elderly patients with type 2 diabetes mellitus: Results of the Greek pilot of the ACTIVAGE multicenter randomised control trial

      ea0073aep188
    • Type 1 Diabetes and physical activity – which are the barriers to its practice and what is therole of therapeutic education?

      ea0073aep189
    • The effect of increasing soluble diatery fibre content of meals on postprandial glycaemic and c-peptide response

      ea0073aep190
    • Erythrocytosis in a patient on sodium glucose cotransporter-2 inhibitor

      ea0073aep191
    • Investigation of 5 alpha reductase-1 and aromatase enzyme levels, gene expressions and kisspeptin and nesfatin-1 levels in male patients with metabolic syndrome and hypogonadism

      ea0073aep192
    • Comparative analysis of the methods for differential diagnosis of non-diabetic hypoglycemia (NDH): Beta-hydroxybutyrate and glucagon test

      ea0073aep193
    • Hedonic rating of sucrose is sub-regionally associated with striatal dopamine transporter in humans

      ea0073aep194
    • glycaemic control in patients with Gestational Diabetes requiring betamethasone – a quality improvement project with intravenous insulin infusion protocol

      ea0073aep195
    • Combined vildagliptin + metformin therapy can increase telomerase activity in patients with type 2 diabetes

      ea0073aep196
    • Maternally inherited diabetes and deafness, associated with a novel mitochondrial mutation, complicated by sever hypertriglyceridemia: Case report

      ea0073aep197
    • Elderly patients with Type 2 Diabetes and Covid-19: the impact of glycemic control on the outcomes

      ea0073aep198
    • Diabetes mellitus and COVID-19 – The bidirectional impact

      ea0073aep199
    • IL-18 in the Glucose Continuum

      ea0073aep200
    • Liraglutide for weight management in syndromic obesity: effects in overgrowth adult Beckwith–Wiedemann syndrome

      ea0073aep201
    • Role of circulating cell-free deoxyribonucleic acid in the management of obese patients with breast cancer: Diagnostic impact, prognosis and relationship with obesity

      ea0073aep202
    • Is there an association between sex steroids and biopsy-proven non-alcoholic fatty liver disease in obese men? A cross-sectional analysis of 134 men

      ea0073aep203
    • The role of vitamin D deficiency in the development of latent autoimmune diabetes in adults

      ea0073aep204
    • Prevalence of erectile dysfunction among the subjects with type 2 diabetes mellitus in the indian state of punjab

      ea0073aep205
    • The effect of renin-angiotensin-aldosterone system inhibitors on binary and continuous renal outcomes in subgroups of patients with diabetes: an extensive meta-analysis

      ea0073aep206
    • Correction of oxidative stress in experimental diabetes mellitus by means of natural antioxidants

      ea0073aep207
    • Clinical and biochemical differences in diabetic ketoacidosis in people with type 1 and type 2 diabetes mellitus

      ea0073aep208
    • Clinical and biochemical assessment of erectile dysfunction in men with type 1 diabetes

      ea0073aep209
    • Diabetic bullosis: about 2 cases

      ea0073aep210
    • Selective sodium-glucose cotransporter inhibitors 2 (isglt2) in patients with high risk of amputation

      ea0073aep211
    • Influence of diabetes in heart failure with preserved ejection fraction

      ea0073aep212
    • Analysis of lipid profile in a sample of patients with type 1 diabetes (T1D)

      ea0073aep213
    • Abstract unavailable

      ea0073aep214
    • Rare case of fluoroquinolone induced hypoglycaemia

      ea0073aep215
    • Microvascular complications in type 1 diabetes diagnosed during adulthood: prevalence and predictive factors

      ea0073aep216
    • In the context of acute disease does the same hyperlactatemia cut-off point hold similar meaning in patients with and without Diabetes mellitus? A retrospective study

      ea0073aep217
    • Utilisation of fibrosis-4 (fib-4 score) for screening non-alcoholic fatty liver disease (nafld) in women with type 2 diabetes (t2dm) in real world setting

      ea0073aep218
    • Comparative evaluation of dapagliflozin and empagliflozin influence on the biomarkers of fibrosis and inflammation in patients with type 2 diabetes and very-high risk of cardiovascular events

      ea0073aep219
    • Visceral adiposity index and atherogenic index of plasma: Simple markers of insulin resistance in type 2 diabetic patients

      ea0073aep220
    • Plasma angiopoietin-like 4 protein: Long term evolution after 3 different techniques of bariatric surgery

      ea0073aep221
    • Insulin resistance in association with cardiovascular risk factors and thyroid function

      ea0073aep222
    • Free T4 level may be associated with insulin requirement in gestational diabetes mellitus

      ea0073aep223
    • Treatment transition in a recently described HNF4a-MODY variant: Better late than never?

      ea0073aep224
    • The effect of obesity on the association between type 2 diabetes mellitus and polycystic ovary syndrome: a meta-analysis of observational studies

      ea0073aep225
    • Features of bacterial metabolism of the colon in patients with type 2 diabetes mellitus (T2D) and non-alcoholic fatty liver disease (NAFLD)

      ea0073aep226
    • Diabetes and cftr gene mutations: Prevalence and correlation in patients with cystic fibrosis

      ea0073aep227
    • Association of IDO polymorphism with oxidative status, metabolic control and inflammation in patients with type 2 diabetes mellitus

      ea0073aep228
    • Treatment of psoriasis in patients with type 2 diabetes

      ea0073aep229
    • Use of continuous glucose monitoring for control assessment in type 2 diabetes patients

      ea0073aep230
    • Factors influencing pregnancy planning of women with diabetes

      ea0073aep231
    • Long-term testosterone therapy improves lipid profile in men with functional hypogonadism and overweight or obesity: 12-year observational data from a controlled registry study in a urological setting

      ea0073aep232
    • Efficacy and safety of gp40081 (insulin aspart biphasic 30) compared to novomix 30 flexpen in type 2 diabetes mellitus patients

      ea0073aep233
    • Vildagliptin is a safe and powerful oral antidiabetic drug for elderly adults with type 2 diabetes

      ea0073aep234
    • The relation between cortisol and anthropometric measurements throughout lifespan: A systematic review and meta-analysis

      ea0073aep235
    • The intensity of menopausal hot flushes is associated with values of the hepatic steatosis index

      ea0073aep236
    • Elevated circulating cell-free deoxyribonucleic acid in obese individuals

      ea0073aep237
    • Effect of a 16-week physical activity program on body composition and aerobic capacity parameters in a population of obese youth

      ea0073aep238
    • The efficacy of complex kinesiotherapy in weight loss and improving of carbohydrate metabolism in obesity patients

      ea0073aep239
    • Impact of sleeve gastrectomy on uric acid metabolism in a Tunisian obese group

      ea0073aep240
    • GLP-1 receptor agonists and bariatric surgery in nonalcoholic steatohepatitis

      ea0073aep241
    • Post hip-fracture rehabilitation outcomes of diabetic and non-diabetic elderly patients

      ea0073aep242
    • Impact of supervised physical activity on cardiovascular autonomic status in type 2 diabetes patients

      ea0073aep243
    • Optimization of surgical treatment of patients with diabetic foot syndrome

      ea0073aep244
    • Necrotizing external otitis in diabetic patients: Role of imaging

      ea0073aep245
    • Risk factors associated with diabetic foot amputation among patients hospitalized for diabetic foot ulcer in a public hospital

      ea0073aep246
    • Clinical characteristics and outcomes of elderly type 2 diabetic patients with SARS-COV2 infection: a retrospective single centre study

      ea0073aep247
    • Effect of coronavirus disease on the clinical course of diabeticketoacidosis (DKA) in people with type 1 and type 2 diabetes

      ea0073aep248
    • Efficacy of liraglutide in weight reduction in a patient with HAIR-AN syndrome - case report

      ea0073aep249
    • Evaluation of the results of weight loss at 1 year after bariatric surgery at the regional university hospital of malaga

      ea0073aep250
    • Bupropion/naltrexone associated psoriasis in an obese patient

      ea0073aep251
    • Inhibition of ATG3 ameliorates liver steatosis by increasing SIRT1 in an autophagic-independent action

      ea0073aep252
    • Association between obesity and anxiety: A cross-sectional study in Sfax, Southern Tunisia

      ea0073aep253
    • Characterization of glycemic profile and glucose-lowering treatment in hospitalized patients of a central hospital by main diagnosis and length of stay

      ea0073aep254
    • Audit on GLP-1 mimetics monitoring in East Kent university hospitals UK

      ea0073aep255
    • Real-world experience of Evolocumab for treatment of hyperlipidemia in an outpatient population

      ea0073aep256
    • The optimal HbA1c threshold for predicting diabetes mellitus defined by OGTT in a high-risk population in Algiers about 500 cases

      ea0073aep257
    • HbA1c threshold to predict prediabetes in a non-diabetic population but high risk of diabetes

      ea0073aep258
    • Clinical and immunological profile of newly diagnosed diabetic patients in a cohort of young adults of national hepatitis C Virus survey in Egypt

      ea0073aep259
    • The role of bile acids in the pathogenesis of non-alcoholic fatty liver disease and type 2 diabetes mellitus

      ea0073aep260
    • Self-Management Behavior of the Patients with Type 2 Diabetes: A Cross-Sectional Survey in the Eastern European population (Belarus)

      ea0073aep261
    • Retinol-binding protein in the diagnosis nafld and type 2 diabets

      ea0073aep262
    • Study on INS gene rs689 polymorphism in patients with diabetes mellitus genetic burden

      ea0073aep263
    • Treatment recommendations for dapagliflozin across a cardio-renal and viscero metabolic (crv-m) continuum: an expert consensus delphi study

      ea0073aep264
    • Acute fatty liver of pregnancy masquerading as diabetic ketoacidosis

      ea0073aep265
    • To assess the glucose metabolism using the flash glucose monitoring system (FGMS) in patients with hormone replacement therapy for hypopituitarism

      ea0073aep266
    • p63 induces the fibrosis in NASH

      ea0073aep267
    • Challenges in availability of insulin in Malwa region of Madhya Pradesh, INDIA during COVID-19 lockdown and its impact on perceived stress in patients

      ea0073aep268
    • Factors predictive of glycemic control of pregnant diabetic women

      ea0073aep269
    • Correlation between cystatin C and cardiovascular risk factor in patients with type 2 diabetes mellitus without kidney disease

      ea0073aep270
    • Role of diabetic autonomic neuropathy in development of diabetic cardiomyopathy in patients with diabetes

      ea0073aep271
    • Influence of nutritional status on clinical outcomes among hospitalized patients with covid-19

      ea0073aep272
    • Acute hyperglycemic emergencies during lockdown: COVID-19 collateral damage

      ea0073aep273
    • Sex-specific variations in lipid concentrations following a low-fat diet are mediated by vitamin D status: a 12-week prospective dietary intervention study among Christian Orthodox fasters

      ea0073aep274
    • Low-density lipoprotein cholesterol target achievement in patients with diabetes

      ea0073aep275
    • Heterozygous familial hypercholesterolemia with intolerance to PCSK9 inhibitors

      ea0073aep276
    • Frequency of obesity among individuals with spondylarthritis

      ea0073aep277
    • Response to direct antiviral agents in chronic hepatitis C in patients with metabolic syndrome

      ea0073aep278
    • The gut microbiota phylotypes in obese patients with arterial hypertension and pre-diabetes

      ea0073aep279
    • Effects of Glucagon-Like-Peptide-1 analogue treatment in genetic obesity

      ea0073aep280
    • Effect of elevated hemoglobin A1c on complication rates after bariatric surgery: a retrospective cohort study

      ea0073aep281
    • Role of sarcopenia in cognitive function in patients with morbid obesity before bariatric surgery

      ea0073aep282
    • Diabetic nephropathy in absence of diabetic retinopathy in type 2 diabetes mellitus patients

      ea0073aep283
    • Management of emphysematous pyelonephritis: Report of Two Cases

      ea0073aep284
    • Association of metabolic syndrome and hepatic steatosis in type 2 diabetics

      ea0073aep285
    • Brain perfusion in patients with type 1 diabetes and cognitive dysfunction

      ea0073aep286
    • Predictive factors associated with diabetic kidney disease in adult-onset Type 1 Diabetes

      ea0073aep287
    • The impact of printed educational materials on knowledge in women with gestational diabetes mellitus

      ea0073aep288
    • The effect of empagliflozin on main cardiovascular risk factors in patients with type 2 diabetes with normal and excessive body weight

      ea0073aep289
    • Gestational diabetes:predicting factors for switch to insulin

      ea0073aep290
    • Clinical research out of insulin glargine u300 in type 1 diabetes mellitus patients with frequent hypoglycemia: a real world experience

      ea0073aep291
    • A survey of nutritional issues in type 2 diabetes among patients in khorezm region of uzbekistan

      ea0073aep292
    • Effectiveness of semaglutide in obese patients with type 2 diabetes. a six-month clinical experience

      ea0073aep293
    • Serum ferritin levels correlate with ultrasonography-determined liver steatosis severity in type 2 diabetes patients with NAFLD

      ea0073aep294
    • Risk factors for diabetes mellitus in a high-risk population: About 500 cases

      ea0073aep295
    • Newly diagnosed diabetes in pregnancy among bulgarian pregnant women - national screening in 2019

      ea0073aep296
    • Effect of yog nidra on the self-estimated levels of stress and epworth sleep score in t2dm patient.

      ea0073aep297
    • Abstract unavailable

      ea0073aep298
    • Microbiota disorders in type 2 diabetes and obese patients

      ea0073aep299
    • Evaluation of international experience in the management of patients with diabetes mellitus after liver transplantation

      ea0073aep300
    • Nutritional status of Tunisian women followed for gestational diabetes

      ea0073aep301
    • The role of diabetes in the clinical presentation and prognosis of bell palsy

      ea0073aep302
    • Poor glycemic control in type 2 diabetes: From eating behavior to therapeutic inertia

      ea0073aep303
    • Impact of diabetes mellitus on survival in upper aerodigestive tract squamous cell carcinoma

      ea0073aep304
    • Comparing impact of SGLT2 inhibitors and GLP-1 agonists on lipid profile among the patients with diabetes mellitus Type 2. Results of a prospective 18-week observational study

      ea0073aep305
    • Nutritional impact of tobacco in diabetic patients

      ea0073aep306
    • Characteristics and Prevalence of diagnosed type 1 diabetes among Tunisian adults

      ea0073aep307
    • Screening for dyslipidemia in diabetic patients in a town in the Moroccan desert: the town of Es-Smara. Screening for dyslipidemia in diabetic patients in a town in the Moroccan desert: The town of Es-Smara

      ea0073aep308
    • Achieving target values for measures for peripheral arterial disease, nephropathy and dyslipidemia in type 2 diabetes- two year assessment

      ea0073aep309
    • Vitamin D levels in a cohort of patients with SARS-CoV-2 infection and relationship with disease outcome

      ea0073aep310
    • Impact of the COVID pandemic and lockdown in the glycemic and weight control of patients with type 1 and type 2 diabetes – data from a Portuguese hospital

      ea0073aep311
    • An unusual case of hypoglycaemia

      ea0073aep312
    • Features of the course of metabolic syndrome in latent autoimmune diabetes in adults

      ea0073aep313
    • Evolution of the parameters of liver function after sleeve gastrectomy

      ea0073aep314
    • Diabetic peripheral neuropathy: Predictive factors and management

      ea0073aep315
    • Chronic diabetic kidney disease, senescenceand cardiovascular disease

      ea0073aep316
    • Peculiarities of type 2 diabetes in men with androgenic deficiency

      ea0073aep317
    • Influence of depression on glycemic control in patients with typ1 diabetes

      ea0073aep318
    • Angiotensin-converting enzyme gene (i/d) polymorphism in association with the diabetic nephropathy

      ea0073aep319
    • Bruns–garland syndrome as the first presentation of type 2 diabetes – a report of two cases from Sri Lanka

      ea0073aep320
    • Immune thrombocytopenia presenting with celiac disease and Hashimoto’s Thyroiditis in type 2 diabetes patient: A case report

      ea0073aep321
    • A retrospective analysis of clinical manifestations of patients with acute intermittent porphyria: three case reports and literature review

      ea0073aep322
    • Identification of a novel mutation of the abcc8 gene in a greek subject with mody12

      ea0073aep323
    • Diabetes, a harbinger of pancreatic tumor

      ea0073aep324
    • Association of glucocorticoid receptor gene polymorphism A3669G (9β) with lower glucose concentration 2 hours after OGTT in patients during chronic glucocorticoid treatment

      ea0073aep325
    • A case of hypertriglyceridemia after the use of tamoxifen

      ea0073aep326
    • The impact of violated production of vascular endothelial growth factor expression on thyroid hormones metabolism in obese patients

      ea0073aep327
    • Non alcoholic steatohepatitis related cirrhosis and hepatocellulair carcinoma: A ten years rerospective study

      ea0073aep328
    • The role of obesity management in the reversal of type 2 diabetes mellitus

      ea0073aep329
    • Study on oxidative stress parameters in obesity associated insulin resistance and diabetes mellitus

      ea0073aep330
    • Do metabolic syndrome and diabetes affect skin autofluorescence in patients with morbid obesity?

      ea0073aep331
    • Prevalence of obesity and its association with metabolic diseases in women from low-and-middle income countries (LMICs): A systematic review and meta-analysis

      ea0073aep332
    • Adherence to the mediterranean diet and metabolic syndrome: Potential relationship in patients candidates for bariatric surgery

      ea0073aep333
    • Antipsychotic induced obesity in schizophrenia and GLP-1 analog treatment? – A case-report

      ea0073aep334
    • Trends in dietary food groups and DASH score among adults: A longitudinal study from tehran lipid and glucose study, 2006–2017

      ea0073aep335
    • A case of post-partum diabetic ketoacidosis in a patient with gestational diabetes mellitus

      ea0073aep336
    • A challenging presentation of Catamenial DKA

      ea0073aep337
    • Management of cervicofacial odontogenic cellulitis in diabetics

      ea0073aep338
    • Predictors of masked hypertension in type 2 diabetics

      ea0073aep339
    • Management of carpal tunnel syndrome in diabetic patients

      ea0073aep340
    • Prevention of cardiovascular risk in the elderly with diabetes

      ea0073aep341
    • The effects of COVID-19 pandemic lockdown on metabolic control of people with diabetes

      ea0073aep342
    • The effect of Covid-19 pandemic lockdown on the blood glucose regulation of diabetic patients; one center experience

      ea0073aep343
    • Hypoglycemia in non-diabetic patients

      ea0073aep344
    • The functional status of the thyroid gland in pregnant women with gestational diabetes mellitus

      ea0073aep345
    • Use and effectiveness of dapagliflozin in type 1 diabetes: Clinical experience data of six months

      ea0073aep346
    • Growth factors in trophic disorders in diabetics

      ea0073aep347
    • The impact of functional insulin therapy on the psychological aspect of type 1 diabetics

      ea0073aep348
    • Implementation of flash glucose monitoring system in a regional hospital in the province of Cordoba

      ea0073aep349
    • Dietary beliefs and behavior of pregnant women with diabetes

      ea0073aep350
    • Seasonal changes of 25(OH) vitamin D among elderly patients

      ea0073aep351
    • Bullosis diabeticorum

      ea0073aep352
    • Screening for obstructive sleep apnoea in type 2 diabetes subjects using STOP-BANG questionnaire

      ea0073aep353
    • Predictors of the development of androgen deficiency in men with type 2 diabetes mellitus

      ea0073aep354
    • Mucormycosis of the ENT sphere in diabetic subjects: About 4 observations

      ea0073aep355
    • Obesity before and during pregnancy-a powerful risk factor for hyperglycemia in pregnant Bulgarian women

      ea0073aep356
    • Isolation of nerve growth factor in blood specimens from patients with type 1 diabetes mellitus

      ea0073aep357
    • Impact of diabetes on liver fibrosis in chronic hepatitis C

      ea0073aep358
    • Type 2 diabetes in young people About 30 cases preliminary results

      ea0073aep359
    • Dunnigan syndrome in Central South Africa: A case report

      ea0073aep360
    • Syndromic mitochondrial diabetes: About three Tunisian families

      ea0073aep361
    • Clinical features of patients with diabetic ketoacidosis and acute pancreatitis

      ea0073aep362
    • Solid pseudopapillarytumor of the pancreas: Report of a special case

      ea0073aep363
    • Characteristics of the metabolic syndrome in the elderly with diabetes

      ea0073aep364
    • Diabetic retinopathy: prevalence and risk factors in a type 2 diabetic population

      ea0073aep365
    • Diabetes-related knowledge among type 2 diabetic patients in Sfax, south Tunisia

      ea0073aep366
    • Quality improvement project on pilot joint diabetes-renal clinics in a district general hospital in United Kingdom

      ea0073aep367
    • Type 1 diabetes and Klinfelter syndrome: A case report

      ea0073aep368
    • Seasonal variation of diagnosis of Type 1 diabetes mellitus: A real phenomenon-Preliminary results

      ea0073aep369
    • The peculiarities of diabetes in the elderly

      ea0073aep370
    • Epidemiological aspects and therapeutic conduct necrosant fungal ear infections: about 20 cases

      ea0073aep371
    • Atypical presentation of Type 1 diabetes mellitus

      ea0073aep372
    • Diabetic ketoacidosis precipitated by COVID-19 in patient without respiratory symptoms: 2 case reports

      ea0073aep373
    • Wolfram syndrome: A diagnostic challenge

      ea0073aep374
    • Iatrogenic hypercalcemia and depression. A case report

      ea0073aep375
    • Pancreatic cancer masquerading as uncontrolled diabetes

      ea0073aep376
    • The estimation of comorbid endocrine and metabolic disorders based on CIRS score in emergency workers of the Chernobyl accident having cardiovascular diseases

      ea0073aep377
    • Prescription of Statins in the elderly with diabetes

      ea0073aep378
  • Endocrine-Related Cancer
  • • Ectopic cushing’s syndrome due to an acinic type parotid carcinoma

      ea0073aep379
    • Multiple metastases of parathyroid carcinoma and papillary thyroid carcinoma in a female patient treated with long-term hemodialysis

      ea0073aep380
    • Case report: Secondary adrenal insufficiency and primary hypothyroidism following Nivolumab therapy in a patient with metastatic melanoma

      ea0073aep381
    • Nutritional assessment and Ghrelin system as predictors of clinical evolution in gastro-enteropancreatic neuroendocrine neoplasms

      ea0073aep382
    • Paraganglioma of the basis cranii due to somatic mutations ind SDHB and PTEN genes

      ea0073aep383
    • Oncogenic role of splicing factor SRSF2/SC35 in pancreatic and prostate adenocarcinomas

      ea0073aep384
    • Ectopic ACTH secretion from a metastatic gastric carcinoma with neuroendocrine component

      ea0073aep385
    • Testosterone replacement therapy(TRT) and prostate cancer

      ea0073aep386
    • MiR-146b, -21, -221, -222, -181b expression is related to clinicopathologic features of PTC

      ea0073aep387
    • Clinical, genetic & imaging characteristics of mediastinal paraganglioma – a case series

      ea0073aep388
    • Levels of Pro-inflammatory biomarkers in Papillary thyroid cancer

      ea0073aep389
    • Assessment of different markers of ovarian reserve in women with differentiated thyroid cancer treated with radioactive iodine

      ea0073aep390
    • A rare cause of postmenopausal hirsutism – granulosa cell tumor of the ovary

      ea0073aep391
    • Malignant pheochromocytomas and paragangliomas: clinical and pathological characteristics of a tertiary hospital’ cohort

      ea0073aep392
    • Severe hypoglycemia: First manifestation of an advanced hepatocellular carcinoma

      ea0073aep393
    • Untreated phaeochromocytoma and co-existing severe pulmonary hypertension: Friend or foe?

      ea0073aep394
    • 131I-MIBG treatment in malignant pheochromocytoma: A case report

      ea0073aep395
    • Parathyroid carcinoma: A case report

      ea0073aep396
    • Anticancer activity of hydroxytyrosol and five semisynthetic lipophilic derivatives in prostate cancer cells

      ea0073aep397
    • Clinical presentation, phenotype, and germline variants of pheochromocytoma and paraganglioma: A three-decade clinical experience

      ea0073aep398
    • Heterogeneity of the clinical presentation of the MEN1 LRG_509t1 c.781C > T (p.Leu261Phe) variant within a three-generation family

      ea0073aep399
    • CGMS-monitored preoperative diazoxide therapy of a pancreatic insulinoma: A case report

      ea0073aep400
    • Association of gastric GIST and Cushing syndrome

      ea0073aep401
    • Gonadal dysfunction in male patients with neuroendocrine tumors

      ea0073aep402
    • Neuroendocrine neoplasms of the larynx: About 4 cases

      ea0073aep403
  • Environmental Endocrinology
  • • Cadmium levels in human breast tissue and estradiol serum levels: Dose-response data analyses

      ea0073aep404
    • Development of in vitro rat, dog and human deiodinase inhibition assays with LC-MS/MS analysis for the identification of endocrine disruptors

      ea0073aep405
  • General Endocrinology
  • • Thoracic trauma associated gynecomastia

      ea0073aep406
    • Arrhythmias and cardiac conduction disorders in patients with acromegaly

      ea0073aep407
    • A new cause of endogenous hyperinsulinism?

      ea0073aep408
    • Characterization of neuroinflammatory makers and related-genetic variants in athletes from a long duration ultramarathon mountain cycling race and endurance exercises

      ea0073aep409
    • Successful treatment of nesidioblastosis during the time of pandemic: A case report

      ea0073aep410
    • Post-menopausal virilizing tumor of the ovary

      ea0073aep411
    • Psychological Impact of COVID-19 national lockdown meAsures on tRansgenDer people in Italy: The PICARD study

      ea0073aep412
    • Evaluation of serum levels of chemerin and resistin in patients with rheumatoid arthritis. Two adipokines at the crossroad between rheumatology and endocrinology

      ea0073aep413
    • Menopausal hormone therapy and women’s health: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials and observational epidemiological studies

      ea0073aep414
    • Cushing’s syndrome: Do Cushing’s patients have similar diagnostic and treatment journeys and outcomes to mine?

      ea0073aep415
    • A single-center observational study of patients with ectopic ACTH syndrome

      ea0073aep416
    • Design of an online platform to support young diabetics transitioning to adult care: an experiment at the endocrinology service of casablanca university hospital

      ea0073aep417
    • Designing a chatbot for young diabetics: Unprecedented experiment at the endocrinology service of the casablanca university hospital

      ea0073aep418
    • Treatment approach of insulinoma

      ea0073aep419
    • Clinical characteristics of organic hypoglycemia

      ea0073aep420
    • Epidemiological aspects of adrenal insufficiency detected by the Synachten test and insulin hypoglycemia during withdrawal from prolonged corticosteroid therapy

      ea0073aep421
    • The effect of COVİD-19 process on patients with endocrinological disease in a pandemic hospital: What Happened to the others?

      ea0073aep422
    • COVID-19: Is there an urgent need to further assess how Cushing syndrome patients have reacted to this pandemic and what mechanisms are in place to support them?

      ea0073aep423
    • The association of Vitamin D deficiency with COVID-19 severity and mortality

      ea0073aep424
    • Serum 25(OH)D level in patients with COVID-19

      ea0073aep425
    • Telehealth experience of endocrinology research centre

      ea0073aep426
    • A case of severe erosive rheumatoid arthritis developed in an elderly male patient after bilateral adrenalectomy performed for ectopic Cushing’s syndrome

      ea0073aep427
    • Sonoelastographic characteristics of parathyroid tumors

      ea0073aep428
    • Case report: The spectrum of autoimmune thyroid disease in association with chromosome 18p deletion syndrome

      ea0073aep429
    • Sulfamethoxazole/Trimethoprim associated hypoglycaemia in a patient with renal transplantation history

      ea0073aep430
    • A giant GIST of the greater omentum in a female transsexual patient, hopefully not a side effect of hormonal therapy

      ea0073aep431
    • Endocrine function in centenarians

      ea0073aep432
    • Potential endocrine markers of severity and outcomes in critical patients with COVID-19

      ea0073aep433
    • Drinking only when thirsty or when eating solids can normalize serum sodium levels in most patients with SIADH and a high fluid intake, regardless of Urine Osmolarity

      ea0073aep434
    • Congenital adrenal hyperplasia due to 3 beta hydroxysteroid dehydrogenase deficiency About two cases

      ea0073aep435
    • Analysis of glycemic variability in patients with diabetes mellitus type 2

      ea0073aep436
    • Insulinoma during pregnancy: A case report

      ea0073aep437
    • Insulinoma: a challenge for a diagnosis

      ea0073aep438
    • A case report of cerebral salt wasting incorrectly diagnosed as the syndrome of inappropriate antidiuretic hormone secretion

      ea0073aep439
    • Myasthenia during multiple autoimmune syndrome: About two observations

      ea0073aep440
    • Association of Hadju Cheney syndrome with adrenal insufficiency in a diabetic patient: A rare association

      ea0073aep441
    • Corticosteroids – 70 years of balancing between good and bad

      ea0073aep442
    • Monitoring of patients on high-dose long-term steroids in a rheumatology outpatient service

      ea0073aep443
    • Abstract unavailable

      ea0073aep444
    • Vitamin D deficiency in young adults and the question of the need for early replacement for the primary prevention of osteoporosis

      ea0073aep445
    • An audit of Multiple Endocrine Neoplasia type-1 (MEN-1) surveillance

      ea0073aep446
    • Attitudes of physicians towards the guideline-recommended LDL target levels in diabetic dyslipidemia

      ea0073aep447
    • Biological activity of thrombopoietin receptor agonists: development of in vitro functional and binding assays

      ea0073aep448
    • Parameters of successful telephone endocrinology consultation during covid-19 pandemic

      ea0073aep449
    • Role of estradiol and progesterone in fragmented sleep of castrated rats

      ea0073aep450
    • The (epi)genetic basis of gender incongruence

      ea0073aep451
    • Growth hormone treatment in turner syndrome: How is the statural growth after one year?

      ea0073aep452
    • The association of angiotensin converting enzyme inhibitors and receptor blockers with COVID-19 severity and mortality

      ea0073aep453
    • Acute pancreatitis in a covid-19 patient

      ea0073aep454
    • Profil of vitamin D in patients with idiopathic short stature: About 62 cases

      ea0073aep455
    • Carney complex – a rare cause of Cushing’s syndrome

      ea0073aep456
  • Pituitary and Neuroendocrinology
  • • A rare case of pituitary apoplexy likely combined to hypophysitis in an old man with SARS-CoV-2 pneumoniae

      ea0073aep457
    • Pituitary apoplexy lead to disappearance of adenoma; two case reports

      ea0073aep458
    • Cushing’s disease presenting as pituitary apoplexy: Challenges of diagnosis and treatment

      ea0073aep459
    • Pituitary tuberculosis: A clinical challenge

      ea0073aep460
    • A rare case of acromegaly developed in a patient with multicentric Castleman disease and complete disappearance of lymphadenopathies after treatment with Lanreotide Autogel

      ea0073aep461
    • Cardiac remodeling in patients with childhood-onset craniopharyngioma – Results of HIT-Endo and Kraniopharyngeom 2000/2007

      ea0073aep462
    • Epidemiology of acromegaly in south-eastern Norway

      ea0073aep463
    • The duration of postoperative steroid replacement therapy may not have a predictive role for recurrence risk of Cushing’s disease

      ea0073aep464
    • Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia and healthy volunteers

      ea0073aep465
    • Study of the brain system for motor control in prader willi syndrome

      ea0073aep466
    • The GLP-1 receptor agonist dulaglutide reduces fluid intake in primary polydipsia: A randomised controlled trial

      ea0073aep467
    • The diagnostic and predictors of postoperative diabetes insipidus

      ea0073aep468
    • The usage of aripiprazole as a single agent in the treatment of hyperprolactinemia associated with diogenes syndrome- a novel approach

      ea0073aep469
    • Nonfunctioning pituitary adenomas: What can we do? What we did

      ea0073aep470
    • Association between fibroblast growth factor-21 and carotid intima media thickness in patients with acromegaly

      ea0073aep471
    • Age and sex differences among patients with acromegaly

      ea0073aep472
    • Panhypopituitarism without pituitary ischemia after hantavirus infection

      ea0073aep473
    • Pulmonary thromboembolism-caused acute severe euvolemic hyponatremia complicated by COVID-19 infection: A case report

      ea0073aep474
    • Recovery of reproductive function under indomethacin treatment in a woman with langerhans cell histiocytosis: A case report

      ea0073aep475
    • Growth Hormone (GH) treatment in adults with Prader-Willi Syndrome (PWS) restores plasma kisspeptin to normal levels

      ea0073aep476
    • Body composition and nuchal skinfold thickness in pediatric brain tumor patients

      ea0073aep477
    • Uncured acromegaly, the dark side of the moon: a cross- sectional study

      ea0073aep478
    • Metabolic profile in patients with prolactinoma before and on dopamine agonist therapy

      ea0073aep479
    • What should be the optimal testosterone level to improve the symptoms of hypogonadism in male macroprolactinomas?

      ea0073aep480
    • Pituitary function after transsphenoidal surgery including measurement of basal morning cortisol as predictor of adrenal insufficiency

      ea0073aep481
    • Factors that contribute to dopamine agonist resistance of prolactinomas

      ea0073aep482
    • Electrolyte disturbances in hospitalized patients with COVID-19

      ea0073aep483
    • Spontaneous remission of cushing’s disease – a case report

      ea0073aep484
    • Hypopituitarism in systemic diseases

      ea0073aep485
    • A successful surgical outcome in thyrotropin-secreting pituitary macrodenomas

      ea0073aep486
    • Case report: Girl with short stature with no response to growth hormone treatment

      ea0073aep487
    • Pituitary surgery in northern ireland: A twenty year retrospective population based analysis

      ea0073aep488
    • Disease activity is associated with depression and anxiety in cushing’s syndrome during COVID-19 pandemic

      ea0073aep489
    • Third month MRI predicts macroprolactinoma reduction after cabergoline therapy

      ea0073aep490
    • The role of cannulated prolactin test in females of reproductive age presenting with isolated mild persistent hyperprolactinaemia on random sampling

      ea0073aep491
    • GH and IGF-1 discrepancies in acromegaly patients after pituitary surgery – an observational single-center study

      ea0073aep492
    • Growth hormone treatment for adults with Prader-Willi syndrome: A meta-analysis

      ea0073aep493
    • Cabergoline treatment for non functioning pituitary macroadenomas

      ea0073aep494
    • Efficacy and safety of cyberknife stereotactic radiosurgery in acromegaly

      ea0073aep495
    • Pituitary apoplexy: Clinical features, management and outcomes-a retrospective study

      ea0073aep496
    • Kallmann syndrome due to a mutation in ANOS1 gene and monoallelic mutation in GNRHR gene

      ea0073aep497
    • The role of endoscopic ultrasonography for localization of sporadic and men-1 syndrome associated insulinomas: Case series

      ea0073aep498
    • Ectopic cushing’s syndrome: Report of 5 cases from a tertiary care center

      ea0073aep499
    • Cerebral infarction in childhood-onset craniopharyngioma patients – results of kraniopharyngeom 2007

      ea0073aep500
    • Clinical features, diagnostic criteria and treatment outcomes in 40 patients with thyrotropin-secreting pituitary tumors

      ea0073aep501
    • White blood cell count: A potential useful tool for suspected Cushing’s syndrome

      ea0073aep502
    • Screening of acromegalia among patients with endocrine and somatic pathology